<SEC-DOCUMENT>0001628280-23-031458.txt : 20230906
<SEC-HEADER>0001628280-23-031458.hdr.sgml : 20230906
<ACCEPTANCE-DATETIME>20230905195616
ACCESSION NUMBER:		0001628280-23-031458
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230905
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Termination of a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230906
DATE AS OF CHANGE:		20230905

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		231237507

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cpix-20230905.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:8cc30226-89a6-4c73-9ac2-669e1e710de4,g:6b0b6ef1-9ebe-4b40-895e-243bdae26558,d:002ad7f50e704eedbf52f84cc3d1dc40--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cpix-20230905</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001087294</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-23">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cpix-20230905.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-05</xbrli:startDate><xbrli:endDate>2023-09-05</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i002ad7f50e704eedbf52f84cc3d1dc40_1"></div><div style="min-height:29.25pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:174%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:144%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="margin-top:11pt;padding-left:108pt;padding-right:108pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">September 5, 2023 (<ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">September 5, 2023</ix:nonNumeric>)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of Report (date of earliest event reported)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">CUMBERLAND PHARMACEUTICALS INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.059%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Tennessee</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-33637</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">62-1765329</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">1600 West End Avenue, Suite 1300</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Nashville</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Tennessee</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">37203</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(Address of Principal Executive Offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">615</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">255-0068</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Registrant's telephone number, including area code</span></div><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span><br/></span></div><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, no par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">CPIX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-21">&#9744;</ix:nonNumeric></span></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i002ad7f50e704eedbf52f84cc3d1dc40_4"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.01 Entry into a Material Definitive Agreement.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">A New Revolving Loan Agreement</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 5, 2023, Cumberland Pharmaceuticals Inc. (the &#8220;Company&#8221; or &#8220;Cumberland&#8221;) entered into a new Revolving Credit Loan Agreement with Pinnacle Bank (the &#8220;New Pinnacle Agreement&#8221;). The New Pinnacle Agreement provides for an aggregate principal funding amount of up to $25 million. It provides an initial revolving line of credit of up to $20 million with the ability for Cumberland to increase the amount to $25 million, under certain conditions. The New Pinnacle Agreement has a three year term expiring on October 1, 2026. The interest rate is based on a benchmark (Term SOFR) plus a spread of 2.75%. Cumberland is subject to one financial covenant, the maintenance of a Funded Debt Ratio, as such term is defined in the New Pinnacle Agreement referenced in Exhibit 10.1 below, and determined on a quarterly basis. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.02 Termination of a Material Definitive Agreement.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">The Prior Loan Agreement</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 5, 2023, the Company entered into the New Pinnacle Agreement. The material terms and conditions to the extent required are included in Item 1.01 above and are incorporated by reference into this Item 1.02. Effective upon the execution of the New Pinnacle Agreement described in Item 1.01 above, the prior Revolving Credit Loan Agreement, as amended, originally dated July 28, 2017, by and between the Company and Pinnacle Bank (the "Prior Pinnacle Agreement") was terminated. The Company incurred no early termination penalties upon termination of the Prior Pinnacle Agreement and the remaining outstanding balance of  $5.1 million was transferred to the New Pinnacle Agreement.  The foregoing description of the Prior Pinnacle Agreement (as amended) is qualified in its entirety by reference to Exhibit 10.34, 10.35, 10.36, 10.37, 10.41, 10.42, 10.43, 10.45, 10.46 and 10.47 to the Company&#8217;s Annual Report on Form 10-K filed on March 13, 2023.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 5, 2023, the Company entered into the New Pinnacle Agreement. The material terms and conditions to the extent required are included in Item 1.01 above and are incorporated by reference into this Item 2.03.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Item 9.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Financial Statements and Exhibits</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;(d)  Exhibits</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.461%"><tr><td style="width:1.0%"></td><td style="width:18.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cumberlandpharm-arloanagre.htm">10.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cumberlandpharm-arloanagre.htm">Revolving Credit Loan Agreement, dated as of September 5, 2023, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div id="i002ad7f50e704eedbf52f84cc3d1dc40_7"></div><div style="margin-top:11.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:11.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:16.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:24.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.386%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumberland Pharmaceuticals Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: September 5, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ John Hamm</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Hamm</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>cumberlandpharm-arloanagre.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i1259dd71c36e494585c8854cc2abde23_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AMENDED AND RESTATED REVOLVING CREDIT LOAN AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">THIS AMENDED AND RESTATED REVOLVING CREDIT LOAN AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Loan Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is made and entered into as of September 5, 2023 by and between CUMBERLAND PHARMACEUTICALS INC., a Tennessee corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and PINNACLE BANK, a Tennessee banking corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">RECITALS&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">Borrower and Lender are party to the Prior Loan Agreement, as defined herein. </font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">Borrower and Lender desire to amend and restate the Prior Loan Agreement as set forth herein. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, the Borrower and the Lender agree as follows&#58;</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ARTICLE I</font><font style="color:#2f5496;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:19.2pt"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LOAN</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.09pt;text-decoration:underline">Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Subject to the Conditions Precedent and the other terms and conditions contained in this Agreement and in the other Loan Documents, and in reliance upon the representations, warranties and covenants in this Agreement and the other Loan Documents, Lender agrees to make Advances to Borrower on a revolving credit basis up to $20,000,000.00 from time to time until the Maturity Date, as evidenced by and pursuant to the Note. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Advances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Borrower shall comply with the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> herein and this Agreement concerning the procedure to follow when requesting an Advance under the Note.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.09pt;text-decoration:underline">Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Interest shall accrue on all amounts advanced under the Note at the Applicable Rate, as described within the Note, except that interest shall accrue at the Default Rate following the occurrence of an Event of Default (regardless of whether notice thereof has been given to Borrower).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.09pt;text-decoration:underline">Borrowing Procedures for the Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Borrower shall give the Lender written notice requesting an Advance (or telephonic notice promptly confirmed in writing), substantially in the form and substance acceptable to Lender (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Notice of Revolving Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), prior to 11&#58;00 a.m. (Nashville Time) on the requested date of each Advance. Each Notice of Revolving Borrowing shall be irrevocable and shall specify (i) the aggregate principal amount of such Advance, and (ii) the date of such Advance (which shall be a Business Day). If such request is received prior to 11&#58;00 a.m. (Nashville Time), Lender shall use its best efforts to fund an Advance on the same day. Borrower acknowledges that Lender may be delayed in funding an Advance because of the need to confirm the dollar-for-dollar collateralization requirements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.09pt;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Proceeds of the Note shall be used for working capital and general corporate purposes. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.09pt;text-decoration:underline">Payments to Lender&#8217;s Office&#59; Right of Offset</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each payment under the Note shall be made to Lender at Lender&#8217;s office for the account of Lender in United States currency on the date such payment is due. Lender may, but shall not be obligated to, debit the amount of any such payment that is not made by such time to any ordinary deposit account of Borrower with Lender (excluding any accounts held in Borrower&#8217;s name as a trustee or fiduciary). Lender shall promptly notify Borrower of any such setoff, but Lender&#8217;s failure to give such notice shall not affect the validity thereof.</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-1-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.09pt;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Commitment Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Borrower shall pay to the Lender a commitment fee related to the loan evidenced by the Note in the amount equal to $20,000.00.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Non-Use Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. On each March 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, June 30</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, September 30</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> until and including the Maturity Date, the Borrower shall pay to Lender a fee equal to twenty-five (25) basis points of the average unused availability under the Note during the preceding calendar quarter, such fee to be prorated for any partial quarter&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the principal amount of the Note is increased, then the twenty-five (25) basis points non-use fee shall be calculated to include the unused portion of the increased principal amount. The non-use fee shall be calculated within fifteen (15) days of each quarter end and shall be immediately paid by Borrower upon notice of such amount. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.09pt;text-decoration:underline">Increase of Availability Under Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower, from time to time, may request in writing that the Lender increase the principal amount available under the Note by an aggregate principal amount of up to an additional $5,000,000.00&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Lender in the exercise of its sole and absolute discretion shall determine whether it will or will not fund any requested increase. In connection with any request by the Borrower for an increase, the following shall apply&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">each approved increase must be in a minimum amount of not less than $1,000,000.00&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">no request for an increase shall be delivered to Lender less than ninety (90) days prior to the Maturity Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the Borrower&#8217;s request to the Lender for an increase shall be made in writing at least thirty (30) Business Days prior to the date the Borrower desires the requested increase to be funded and in connection with any such written request the Borrower shall submit&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">the purpose for the increase,</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">Borrower&#8217;s calculations, including pro-forma calculations, establishing to Lender&#8217;s satisfaction that none of the financial covenants set forth in this Agreement have been violated, nor will such be violated immediately after any approved funding, and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">Borrower&#8217;s certification that all representations and warranties contained in the Loan Documents are true and correct as of the date of the request, and that no Default or Events of Default exists or is threatened.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event the Lender elects to fund any requested increase, Borrower shall&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">cause the Lender to receive, at Borrower&#8217;s expense, satisfactory evidence that the lien and security interest against the Collateral remains a first-priority perfected security interest in favor of Lender, subject to no encumbrance objectionable to Lender&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">cause the Lender to receive all loan documentation required by Lender to evidence the increase&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">pay to Lender all costs and expenses incurred by Lender in connection with the increase, including, without limitation, indebtedness tax, UCC filing costs, and reasonable attorney fees&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">pay to Lender a commitment fee in an amount determined by Lender at the time of said increase.</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-2-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.09pt;text-decoration:underline">Usury</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The parties to this Agreement intend to conform strictly to applicable usury laws as presently in effect. Accordingly, if the transactions contemplated hereby would be usurious under applicable law (including the laws of the United States of America and the State of Tennessee), then, in that event, notwithstanding anything to the contrary in any Loan Document, Borrower and Lender agree as follows&#58; (a) the aggregate of all consideration that constitutes interest under applicable law which is contracted for, charged or received under any of the Loan Documents or otherwise in connection with the Indebtedness, shall under no circumstance exceed the amount collectible at the maximum lawful rate of interest permitted by applicable law, and any excess shall be credited on the Indebtedness by the holder thereof (or, if the Indebtedness shall have been paid in full, refunded to Borrower)&#59; and (b) if the maturity of the Indebtedness is accelerated by reason of an election of the holder resulting from any Event of Default or otherwise, or in the event of any required or permitted prepayment, then such consideration that constitutes interest may never include more than the maximum amount of interest permitted by applicable law, and excess interest, if any, for which this Agreement provides, or otherwise, shall be canceled automatically as of the date of such acceleration or prepayment and, if previously paid, shall be credited against the Indebtedness (or, if the Indebtedness shall have been paid in full, refunded to Borrower).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.09pt;text-decoration:underline">General Interest Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Computation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary herein or in any other Loan Document, all interest under the Note shall be computed on the basis of a year of&#160;360 days, and in each case shall be payable for the actual number of days elapsed (including the first day but excluding the last day).  All interest under the Note shall be computed on a daily basis based upon the outstanding principal amount of the Note as of the applicable date of determination.  The Benchmark shall be determined by the Lender, and such determination shall be conclusive absent manifest error.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Term SOFR Conforming Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In connection with the use or administration of Term SOFR, the Lender will have the right to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party.  The Lender will promptly notify the Borrower of the effectiveness of any Conforming Changes in connection with the use or administration of Term SOFR.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.59pt;text-decoration:underline">Benchmark Replacement Settings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary herein or in any other Loan Document, upon the occurrence of a Benchmark Transition Event, the Note shall be deemed amended to replace the then-current Benchmark with the Benchmark Replacement. Any such amendment with respect to a Benchmark Transition Event will become effective at 5&#58;00 p.m. (New York City time) on the fifth (5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) Business Day after the Lender notifies the Borrower of such Benchmark Replacement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that no replacement of a Benchmark with a Benchmark Replacement pursuant to this item (a) will occur prior to the applicable Benchmark Transition Start Date.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement Conforming Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In connection with the use, administration, adoption or implementation of a Benchmark Replacement, the Lender will have the right to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notices&#59; Standards for Decisions and Determinations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Lender will promptly notify the Borrower of (i)&#160;the implementation of any Benchmark Replacement and (ii)&#160;the effectiveness of any Conforming Changes in connection with the use, administration, adoption or implementation of a Benchmark Replacement.  The Lender will promptly notify the Borrower of the removal or reinstatement of any tenor of a Benchmark pursuant to item (d) below.  Any determination, decision or election that may be made by the Lender pursuant to this section, including any determination with respect to a tenor, rate or adjustment or of the occurrence or </font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-3-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action or any selection, will be conclusive and binding absent manifest error and may be made in its sole discretion and without consent from any other party, except, in each case, as expressly required herein or in another Loan Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Unavailability of Tenor of Benchmark</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary herein or in any other Loan Document, at any time (including in connection with the implementation of a Benchmark Replacement), (i)&#160;if the then-current Benchmark is a term rate (including the Term SOFR Reference Rate) and either (A)&#160;any tenor for such Benchmark is not displayed on a screen or other information service that publishes such rate from time to time as selected by the Lender in its reasonable discretion or (B)&#160;the administrator of such Benchmark or the regulatory supervisor for the administrator of such Benchmark has provided a public statement or publication of information announcing that any tenor for such Benchmark is not or will not be representative or in compliance with or aligned with the International Organization of Securities Commissions (IOSCO) Principles for Financial Benchmarks, then the Lender may modify any concept or definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">interest period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; (or any similar or analogous definition) for any Benchmark settings at or after such time to remove such unavailable, non-representative, non-compliant or non-aligned tenor and (ii)&#160;if a tenor that was removed pursuant to clause&#160;(i) above either (A)&#160;is subsequently displayed on a screen or information service for a Benchmark (including a Benchmark Replacement) or (B)&#160;is not, or is no longer, subject to an announcement that it is not or will not be representative or in compliance with or aligned with the International Organization of Securities Commissions (IOSCO) Principles for Financial Benchmarks for a Benchmark (including a Benchmark Replacement), then the Lender may modify the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Applicable Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and&#47;or any concept or definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">interest period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; (or any similar or analogous definition) for all Benchmark settings at or after such time to reinstate such previously removed tenor.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ARTICLE II</font><font style="color:#2f5496;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:15.54pt"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">COLLATERAL AND GUARANTIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">II.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.43pt;text-decoration:underline">Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Obligations shall be secured by a first-priority, perfected security interest in all of the presently existing and hereafter acquired assets of the Borrower and all Guarantors, including, without limitation, their respective accounts, accounts receivable, payments, furniture, equipment, inventory, machinery, general intangibles (including Equity Interests), chattel paper, instruments, documents, contract rights, choses in action, corporate or other business records, marketable securities, stock and other securities, brokerage accounts, depository accounts, cash, cash equivalents, intellectual property rights, trademarks, copyrights, patents, patent applications, trade secrets, goodwill, registrations, licenses, franchises, customer lists, tax refund claims, computer programs, tort claims, and proceeds arising out of or in connection with the foregoing all as evidenced by security agreements, UCC financing statements, and any other documentation, all as evidenced by, and described in more detail in, the Security Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The Obligations shall be secured by all Property hereafter pledged and delivered to Lender to secure the Obligations, and all Property in which any Person has granted or hereafter grants Lender a lien or security interest to secure the Obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">II.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.43pt;text-decoration:underline">Guaranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Obligations shall be jointly and severally guaranteed by the Guarantors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">II.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.43pt;text-decoration:underline">Cross-Collateralization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Any and all Collateral described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above shall stand as security and collateral for all Obligations of the Borrower and Guarantors to Lender, whether incurred pursuant to the terms of the Loan Documents or otherwise, and whether presently existing or hereafter incurred. This cross-collateralization provision is a material factor in Lender&#8217;s willingness to enter into this Agreement and to extend credit hereunder.</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-4-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ARTICLE III</font><font style="color:#2f5496;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:11.88pt"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To induce Lender to enter this Agreement and extend credit under this Agreement, Borrower covenants, represents, and warrants to Lender that as of the date hereof and as of the Closing Date&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.77pt;text-decoration:underline">Existence and Qualification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Borrower is a corporation, legally existing and in good standing under the laws of the State of Tennessee and is duly qualified to do business in each jurisdiction in which a failure to be so qualified would have a Material Adverse Effect. All Guarantors are duly existing and validly formed in the state of their formation, and all Guarantors are duly qualified to do business in each jurisdiction in which a failure to be so qualified would have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.77pt;text-decoration:underline">Power and Authorization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Borrower and the Guarantors are duly authorized and empowered to execute, deliver, and perform under all Loan Documents to which each is a party, in accordance with their respective organizational documents. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.77pt;text-decoration:underline">Binding Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement is, and the Note and other Loan Documents to which each is a party when executed and delivered in accordance with this Agreement will be, legal, valid and binding upon and against the Borrower and the Guarantors, as applicable, and their respective Properties, enforceable in accordance with their respective terms, subject to no defense, counterclaim, set-off, or objection of any kind.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.77pt;text-decoration:underline">No Legal Bar or Resultant Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The execution, delivery and performance of the Loan Documents by the Borrower and each Guarantor does not constitute a default under, and will not violate any provisions of the organizational documents of the Borrower or any Guarantor or any contract, agreement, law, regulation, order, injunction, judgment, decree, or writ to which the Borrower or any Guarantor is subject, nor result in the creation or imposition of any lien upon any Properties of Borrower or any Guarantor, other than those contemplated by the Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.77pt;text-decoration:underline">No Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The execution, delivery, and performance of the Loan Documents by the Borrower and each Guarantor does not require the consent or approval of any other Person, if the failure to obtain the same would have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.77pt;text-decoration:underline">Financial Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The audited consolidated financial statements of the Borrower and each Guarantor for the fiscal year ended December 31, 2022, were prepared in accordance with GAAP, consistently applied, and such financial statements present fairly the financial condition of the Borrower and each Guarantor, as applicable, as of the date or dates and for the period or periods stated therein, subject to finalizing adjustments determined not to be material. No Material Adverse Change has occurred since the date of such financial statements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.77pt;text-decoration:underline">Litigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. There is no litigation, legal or administrative proceeding, investigation, or other action of any nature pending or, to the knowledge of the Borrower, threatened against or affecting the Borrower or any Guarantor that involves the possibility of any judgment or liability not fully covered by insurance and that may have a Material Adverse Effect on the business or the Properties of the Borrower or any Guarantor or their respective ability to carry on their respective business as now conducted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.77pt;text-decoration:underline">Taxes&#59; Governmental Charges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Borrower and each Guarantor have filed or caused to be filed all tax returns and reports required to be filed. The Borrower and each Guarantor have paid all due and payable taxes, assessments, fees, and other governmental charges levied upon them or upon any of their respective Properties or income including interest and penalties. Borrower and each Guarantor have made all required withholding deposits.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.77pt;text-decoration:underline">Title, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Borrower and each Guarantor have good title to the Collateral, free and clear of all liens except those securing the Indebtedness and Permitted Liens. Neither the Borrower nor any of the Guarantors own any real property.</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-5-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.27pt;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Except to the extent that a failure to do so will not have a Material Adverse Effect, the Borrower and each Guarantor possess or have the right to use all trademarks, service marks, copyrights, trade names, patents, licenses, and other intellectual property, and rights therein, as are necessary for the conduct of its business as now conducted and presently proposed to be conducted, without conflict with the rights or claimed rights of others.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.27pt;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Except to the extent that the same will not have a Material Adverse Effect, neither the Borrower nor any Guarantor is in default in any respect that affects its business, Properties, operations, or condition, financial or otherwise, under any indenture, mortgage, deed of trust, credit agreement, note, agreement, or other instrument to which the Borrower and any Guarantor is a party or by which it or their Properties are bound. Neither the Borrower nor any Guarantor is in violation of its organizational documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.27pt;text-decoration:underline">Casualties&#59; Taking of Properties, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Neither the business nor the Properties of the Borrower and any Guarantor have been affected as a result of any fire, explosion, earthquake, flood, drought, windstorm, accident, strike or other labor disturbance, embargo, requisition or taking of property, cancellation of contracts, permits, concessions by any domestic or foreign government or any agency thereof, riot, activities of armed forces or acts of God or of any public enemy in such a way as to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.27pt;text-decoration:underline">Compliance with Laws, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Except to the extent the same will not have a Material Adverse Effect, neither the Borrower nor any Guarantor is in violation of any law, judgment, decree, order, ordinance, or governmental rule or regulation to which the Borrower or any Guarantor or any of their respective Properties is subject, including without limitation any Environmental Law. Neither the Borrower nor any Guarantor has failed to obtain any material license, permit, franchise, or other governmental authorization necessary to the ownership of any of their respective Properties or to the conduct of their respective business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.27pt;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Borrower and all Guarantors are in compliance in all material respects with the applicable provisions of ERISA. Neither the Borrower nor any Guarantor has incurred any material &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">accumulated funding deficiency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; within the meaning of ERISA, and has not incurred any material liability to PBGC in connection with any Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.27pt;text-decoration:underline">Trade Names</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Neither the Borrower nor any Guarantor uses any trade names (and have not used any since the date of their respective formation).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.27pt;text-decoration:underline">Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The only Subsidiaries of the Borrower is the Guarantor and Cumberland Emerging Technologies, Inc.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.27pt;text-decoration:underline">Loans to Others</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Neither the Borrower nor any Guarantor has made a loan to any board member, shareholder, officer, employee, or any other Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.27pt;text-decoration:underline">Leases and&#47;or Warehouse Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The locations at which the Borrower and&#47;or any Guarantor maintain any portion of the Collateral are described on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> also identifies all leases and&#47;or storage agreements related to such locations.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ARTICLE IV</font><font style="color:#2f5496;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:11.26pt"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CONDITIONS PRECEDENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IV.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">Initial Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Lender&#8217;s obligation to enter into this Agreement is subject to the Conditions Precedent that Lender shall have received (or agreed in writing to waive or defer receipt of) all of the following, each duly executed, dated and delivered as of the Closing Date, in form and substance satisfactory to Lender and its counsel&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Note and this Agreement, each duly executed by the Borrower&#59;</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-6-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Resolutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Certified copy of resolution of the applicable governing body of the Borrower authorizing the execution, delivery, and performance of this Agreement and the Note, along with any additional documents executed in connection therewith&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Certificate of Existence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. A certificate of existence regarding the Borrower and all Guarantors certified by the Secretary of State of the formation of such Borrower and&#47;or Guarantors, containing no facts objectionable to Lender, together with appropriate certificates of authorization to do business in the State of Tennessee and any other states in which the Borrower or any Guarantor is required to qualify to do business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">UCC-11 Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. UCC-11 reports for Borrower and each Guarantor from the secretary of state of their state of organization&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Evidence that all insurance required by Lender under this Agreement and any other Loan Document is in place and effective (including, without limitation, any required flood insurance)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt;text-decoration:underline">Other</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Such other documents as Lender may reasonably request.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IV.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">All Advances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. After the Closing Date, Lender&#8217;s obligation to make Advances under the Note is subject to the following additional Conditions Precedent, which must be satisfied each time an Advance is requested&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The representations of the Borrower contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article&#160;III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be true and correct as of the date of the requested Advance, except as to (i) representations and warranties expressly made as of a specified date, which shall remain true and correct as of such specified date, and (ii) changes occurring after the Closing Date caused by transactions permitted under the Loan Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Material Adverse Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. No Material Adverse Event has occurred and is continuing&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. No Default or Event of Default has occurred and continues to exist.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ARTICLE V</font><font style="color:#2f5496;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:14.92pt"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AFFIRMATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Borrower covenants that, during the term of this Agreement (including any extensions hereof) and until all Indebtedness shall have been finally paid in full and all Indebtedness shall have been fully discharged, unless Lender shall otherwise first consent in writing, the Borrower shall&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">V.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.81pt;text-decoration:underline">Financial Statements and Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Promptly furnish to Lender&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Annual Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As soon as available, and in any event within one hundred twenty (120) days after the close of each fiscal year end of the Borrower, cause the Lender to receive the annual audited consolidated financial statements of the Borrower, certified by BDO USA or another independent registered public accounting firm approved by Lender in its reasonable discretion, which financial statements set forth the balance sheet, related statements of income, and cash flows as at the end of such year, all prepared in accordance with GAAP&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Quarterly Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As soon as available and in any event within forty-five (45) days of each quarter end, cause to be delivered to Lender the company prepared consolidated financial statements of the Borrower, setting forth the balance sheet of the Borrower and the related statements of income, and cash flows as of the end of such quarter, all prepared in accordance with GAAP and certified by the Borrower&#8217;s chief financial officer as being true and accurate&#59;</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-7-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Compliance Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As soon as available, and in any event within forty-five (45) days of the last day of the end of each fiscal quarter, the Borrower shall deliver to Lender a Compliance Certificate evidencing Borrower&#8217;s compliance or noncompliance with the financial covenant(s) set forth herein&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Rule 10b5-1 Trading Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As soon as available and in any event within fifteen (15) days of each quarter end, cause to be delivered to Lender (i) copies of its Rule 10b5-1 trading plan, and (ii) a summary of any repurchase or redemption during the prior fiscal quarter outside the parameters of any applicable Rule 10b5-1 trading plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Other Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Promptly upon its becoming available, deliver such other material information about Borrower, the Guarantors, the Collateral, or the Indebtedness as Lender may reasonably request from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">V.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.81pt;text-decoration:underline">Taxes and Other Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Pay and discharge, and cause each Guarantor to pay and discharge, prior to delinquency, all taxes, assessments, and governmental charges or levies imposed upon it or upon any of its income or Property as well as all claims of any kind (including claims for labor, materials, supplies, and rent) which, if unpaid, might become a Lien upon any or all of its Property&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that neither the Borrower nor any Guarantor shall be required to pay any such tax, assessment, charge, levy, or claim if the amount, applicability, or validity thereof shall currently be contested in good faith by appropriate proceedings diligently conducted, no Lien attaches to any of the Property of Borrower and&#47;or any Guarantor or Borrower or any Guarantor, as applicable, has established reserves therefor adequate under GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">V.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.81pt;text-decoration:underline">Maintenance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Maintain, and cause each Guarantor to maintain, their respective organizational existence, name, rights, and franchises.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">V.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.81pt;text-decoration:underline">Further Assurances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Promptly cure, and cause each Guarantor to cure, any defects in the creation, issuance, and delivery of the Loan Documents to which it is a party. Borrower at its expense promptly will execute and deliver, and cause each Guarantor to execute and deliver, to Lender upon request all other and further documents, agreements, and instruments reasonably required in order to comply with or accomplish the covenants and agreements of the Borrower and all Guarantors in the Loan Documents, or to evidence further and to describe more fully any Collateral intended as security for the Indebtedness or to correct any omissions in the Loan Documents, or to state more fully the Indebtedness and agreements set out in any of the Loan Documents, or to perfect, protect, or preserve any Liens created pursuant to any of the Loan Documents, or to make any recordings, to file any notices or to obtain any consents as may be reasonably necessary or appropriate in connection therewith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">V.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.81pt;text-decoration:underline">Accounts and Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Keep books of record and account, and cause each Guarantor to keep books of record and account, in which full, true, and correct entries will be made of all dealings or transactions in accordance with GAAP, except only for changes in accounting principles or practices with which Borrower&#8217;s certified public accountants concur and which changes have been reported to Lender in writing and with an explanation thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">V.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.81pt;text-decoration:underline">Notice of Certain Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Promptly give to Lender, if Borrower learns of the occurrence of any of the following events, notice of (a) any event that constitutes a Default or an Event of Default, together with a detailed statement by a responsible officer of the Borrower of the steps being taken as a result thereof&#59; or (b) the receipt of any notice from, or the taking of any other action by, the holder of any promissory note, debenture, or other evidence of Debt of the Borrower and&#47;or any Guarantor or of any security (as defined under the Securities Act of 1933, as amended) of the Borrower and&#47;or any Guarantor with respect to a claimed default, together with a detailed statement by a responsible officer of the Borrower and&#47;or any Guarantor specifying the notice given or other action taken by such holder and the nature of the claimed default and what action the Borrower and&#47;or any Guarantor is taking or proposes to take with respect thereto&#59; or (c) any legal, judicial, or regulatory proceedings affecting the Borrower or any Guarantor in which the amount involved is material and is not covered by insurance or which, if adversely determined, would have a Material Adverse Effect&#59; or (d) any dispute between the Borrower or any Guarantor and any governmental or regulatory authority or any other person, entity, or agency which, </font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-8-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">if adversely determined, would have a Material Adverse Effect&#59; or (e) a change to the position of Chief Executive Officer of the Borrower at least 30 days prior to the effective date of such change&#59; or (f) any Material Adverse Change, either individually or in the aggregate, in the assets, liabilities, financial condition, business, operations, affairs, or circumstances of the Borrower from those reflected in the financial statements of the Borrower delivered to Lender pursuant to this Agreement or from the facts warranted or represented in any Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">V.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.81pt;text-decoration:underline">Compliance with Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Observe and comply, and cause each Guarantor to observe and comply, (to the extent necessary so that any failure will not have a Material Adverse Effect) with all applicable laws, statutes, codes, acts, ordinances, orders, judgments, decrees, injunctions, rules, regulations, certificates, franchises, permits, licenses, authorizations, and requirements of all federal, state, county, municipal, and other governments, including without limitation all Environmental Laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">V.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.81pt;text-decoration:underline">ERISA Information and Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Except to the extent that a failure to do so will not have a Material Adverse Effect, comply, and cause each Guarantor to comply, with ERISA and all other applicable laws governing any pension or profit sharing plan or arrangement to which the Borrower or any Guarantor is a party or is otherwise subject. The Borrower and any Guarantor shall provide Lender with notice of any &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">reportable event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">prohibited transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or the imposition of a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">withdrawal liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; within the meaning of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">V.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.81pt;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Obtain and maintain in full force and effective the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Hazard insurance, including, without limitation, coverage for fire, vandalism, malicious mischief, earthquake, and windstorm damage, which insurance&#58; (i) must be issued by an insurance company reasonably acceptable to Lender and licensed to transact business in Tennessee, (ii) must contain a standard mortgagee clause designating the Lender, its successors and assigns, as additional insured, and (iii) must contain provisions for written notice to Lender at least thirty (30) days prior to any cancellation, termination, or modification thereof or of any coverage, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if such cancellation or termination is due to non-payment of premiums, the time period for such notice may not be less than ten (10) days&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Public liability insurance issued by an insurance company acceptable to Lender in such amounts and containing such terms as acceptable to Lender, naming Lender as an additional insured&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">All such other insurance as required by the provisions of any other Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ARTICLE VI</font><font style="color:#2f5496;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:11.26pt"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NEGATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Borrower covenants and agrees that, during the term of this Agreement and until all Indebtedness shall have been finally paid in full and all Indebtedness shall have been fully discharged, unless Lender shall otherwise first consent in writing, Borrower will not, nor will Borrower permit any Guarantor, either directly or indirectly&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VI.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">Nature of Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Suffer or permit any Material Adverse Change to be made in the character of the business it or any Guarantor engages in as of the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VI.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">Mergers, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Merge or consolidate, or allow any Guarantor to merge or consolidate, with or into any other Person except through a permitted Acquisition and unless the Borrower or such Guarantor is the surviving entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VI.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">Proceeds of Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Permit the proceeds of the Loan to be used for any purpose other than those permitted under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VI.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Permit any Change in Control of Borrower or any Guarantor. </font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-9-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VI.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">Notice of Additional Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Incur or permit any of the Guarantors to incur any additional Debt without Lender&#8217;s prior written consent with the exception of unsecured borrowings, purchase money loans, and capital lease obligations less than $2,000,000 in the aggregate for the Borrower and the Guarantors combined in any fiscal year&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, prior to any such additional Debt, Borrower shall provide evidence satisfactory to Lender, in form and substance, that no Event of Default will occur or shall be threatened as a result of the incurrence of such additional Debt. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VI.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Voluntarily or involuntarily permit, or allow any Guarantor to permit, any lien or encumbrance to attach to its assets excluding liens in favor of Lender and Liens securing any purchase money Debt permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VI.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">Maximum Funded Debt Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Permit the Funded Debt Ratio of Borrower, as calculated on a rolling four quarter basis for Borrower and its Subsidiaries and measured as of each March 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, June 30</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, September 30</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to exceed 2.50 to 1.00.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VI.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Create or acquire any Subsidiary except through a permitted Acquisition&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the Lender, in its discretion, consents to the creation or acquisition of any Subsidiary, then such approved Subsidiary shall be required to execute and provide such documentation as required by Lender to become a Guarantor hereunder and to grant a first perfected security interest in favor of Lender in all of its assets to secure repayment by Borrower of all Indebtedness.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VI.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">Loans, Advances to Others, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Take, or permit any Guarantor to take, any of the following actions&#58; (a) extend a loan to any Person, or (b) make an investment in any Person other than in a Subsidiary that becomes a Guarantor and that grants a first perfected security interest in its assets in favor of Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that Cumberland Emerging Technologies Inc. is not required to become a Guarantor or grant any such security interest in favor of Lender. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VI.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:10.65pt;text-decoration:underline">Sale of Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Sell or transfer any assets to any Person (i) outside the ordinary course of business or (ii) in excess of $100,000 in the aggregate in any fiscal year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VI.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:10.65pt;text-decoration:underline">Dividends and Repurchase or Redemption of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Borrower shall not be permitted to pay dividends or to repurchase or redeem shares of its stock or that of any Subsidiary except as follows&#58; (i) Borrower may pay dividends and&#47;or repurchase or redeem such stock in an aggregate amount not to exceed $4,000,000 from September 5, 2023 to the Maturity Date&#59; and (ii) shares net settled for restricted share vesting up to $300,000 annually shall not count towards the limitation set forth in item (i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VI.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:10.65pt;text-decoration:underline">Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Borrower may not make any Acquisition, unless&#58; (a) no Default or Event of Default under the Note has occurred or is threatened, and (b) prior to any such Acquisition, Borrower delivers to Lender a pro forma &#8220;Post-Acquisition&#8221; calculation of the financial covenants, which pro-forma calculation shall establish to Lender&#8217;s satisfaction that the Acquisition shall not cause the required financial covenants to be violated. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VI.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:10.65pt;text-decoration:underline">Change in Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Engage in any business in which Borrower and any Guarantor is not currently engaged, except for complimentary lines of business approved in writing by Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VI.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:10.65pt;text-decoration:underline">Cumberland Emerging Technologies, Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Extend a loan or downstream monies in excess of $100,000.00 in the aggregate to Cumberland Emerging Technologies, Inc. without the express prior written consent of Lender. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ARTICLE VII</font><font style="color:#2f5496;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:7.6pt"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EVENTS OF DEFAULT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VII.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.49pt;text-decoration:underline">Events of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Any of the following events shall be considered an Event of Default (and shall be considered a Default pending the passage of time, giving of notice or other condition specified below)&#58;</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-10-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Principal and Interest Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Borrower fails to pay any amount due hereunder, under the Note (including without limitation principal and interest payments) or any other Loan Document within ten (10) days of the applicable due date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, no grace period shall be permitted for the final payment of principal and interest due on any applicable maturity date&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Any representation, warranty, statement (including financial statements), certification or data made or furnished by or on behalf of the Borrower or any Guarantor in connection with this Agreement or any other Loan Document is incorrect in any material respect as of the date as of which the facts therein set forth were stated or certified&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Borrower or any Guarantor fails to perform any of the promises, covenants or obligations contained in or required by this Agreement, the Note, or any other Loan Document within ten (10) days of Borrower&#8217;s or Guarantor&#8217;s, as applicable, receipt of written notice of such failure&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> no notice and cure period shall be applicable to a violation of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article&#160;VI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Involuntary Bankruptcy or Receivership Proceedings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Any of the following events or conditions occurs with respect to the Borrower or any Guarantor and is not dismissed within sixty (60) days&#58; (i) a receiver, custodian, liquidator, or trustee of itself or of any of its respective Property is appointed by the order or decree of any court or agency or supervisory authority having jurisdiction&#59; or (ii) any of its Property is sequestered by court order&#59; or (iii) a petition is filed against it under any state or federal bankruptcy, reorganization, debt arrangement, insolvency, readjustment of debt, dissolution, liquidation or receivership law of any jurisdiction, whether now or hereafter in effect&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Voluntary Petitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Borrower or any Guarantor files (or takes formal company action authorizing the filing of) a voluntary bankruptcy petition or other petition to seek relief under any provision of any bankruptcy, reorganization, debt arrangement, insolvency, readjustment of debt, dissolution or liquidation law of any jurisdiction or consents to the filing of any such petition against it under any such law&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt;text-decoration:underline">Assignments for Benefit of Creditors, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Borrower or any Guarantor makes an assignment for the benefit of its creditors, or admits in writing its inability to pay its debts generally as they become due, or consents to the appointment of a receiver, trustee, or liquidator of itself or of all or any part of its Property&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Cross-Default on Other Debt or Security</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Subject to any applicable grace period or waiver prior to any due date, (i) Borrower or any Guarantor fails to make any payment due on any of its Debt, in excess of $250,000.00, and (ii) any trustee or any holder of such Debt accelerates all of such debt so as to become due prior to its stated maturity or its regularly scheduled dates of payment&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Undischarged Judgments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Any court or other governmental authority renders judgment against the Borrower or any Guarantor for the payment of money in excess of $250,000, payment of which is not fully covered by valid collectible insurance or for which execution is not stayed by bond or otherwise&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">Default Under Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. A default shall occur under any other Loan Document&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. A Change in Control of the Borrower or any Guarantor occurs&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Material Adverse Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. A reasonable determination by Lender that a Material Adverse Change in the business or financial condition of the Borrower or any Guarantor has </font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-11-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">occurred, or that a Material Adverse Change has occurred in the value of the Collateral, or that any other circumstance or event has created a Material Adverse Change&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">Cessation of Business, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> The liquidation of the Borrower or any Guarantor, or the termination or suspension of business of the Borrower or any Guarantor&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt;text-decoration:underline">Sale of Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The sale of all or substantially all of the assets of the Borrower or any Guarantor other than in the ordinary course of business&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Defaults to Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Borrower or any Guarantor defaults to Lender in the performance under any indebtedness or Debt owed to Lender&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Fraud</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Borrower or any Guarantor commits fraud.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VII.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.49pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Upon the occurrence of an Event of Default, Lender may declare the entire principal amount of all Indebtedness then outstanding, including interest accrued thereon, to be immediately due and payable without presentment, demand, protest, notice of protest, or dishonor or other notice of default of any kind, all of which the Borrower hereby expressly waives, and, at Lender&#8217;s sole discretion and option, all obligations of Lender under this Agreement shall immediately cease and terminate unless and until Lender shall reinstate such obligations in writing. Such acceleration and cessation of Lender&#8217;s obligations shall occur automatically, without any declaration by Lender or any notice, upon the occurrence of an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Upon the occurrence of any Event of Default, Lender may also exercise all rights against any of the Collateral described in the Security Documents or afforded a creditor under applicable law, and&#47;or bring an action to protect or enforce its rights under the Loan Documents or seek to collect the Indebtedness by any lawful means. All remedies provided in this Agreement or in any other Loan Documents shall be cumulative, in addition to all other remedies available to Lender under the principles of law and equity or pursuant to any other body of law, statutory or otherwise, and the exercise or partial exercise of any such right or remedy shall not preclude the exercise of any other right or remedy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VII.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.49pt;text-decoration:underline">Right of Set-off</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Upon the occurrence and during the continuance of any Event of Default, Lender is authorized, at any time and from time to time, without notice to the Borrower (any such notice being expressly waived by the Borrower), to set-off and apply any and all deposits (general or special, time or demand, provisional or final) at any time held and other indebtedness at any time owing by Lender to or for the credit or the account of the Borrower against any and all of the Indebtedness, irrespective of whether or not Lender shall have accelerated the Indebtedness or made any demand under this Agreement or the Note and although such obligations may be unmatured. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VII.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.49pt;text-decoration:underline">Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Upon the occurrence of a Default, the Lender, at its option and without liability to the Borrower or to any other Person, may cease funding Advances under the Note until such time as the Default is cured.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VII.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.49pt;text-decoration:underline">Liquidity Cure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For a five (5) day period after the occurrence of an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof (such Event of Default being deemed to have occurred on the date on which the Compliance Certificate for such period is required to be delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof), Borrower may cure such Event of Default by paying down the Loan in an amount that would have resulted in compliance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as of the date of measurement.  From September 5, 2023 to the Maturity Date, Borrower may not exercise the Liquidity Cure provided hereunder more than two (2) times.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ARTICLE VIII</font><font style="color:#2f5496;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:3.94pt"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GENERAL PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.83pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. All notices, requests, demands, directions and other communications (collectively &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) required under this Agreement shall be in writing and shall be sent by hand, by registered or certified mail return receipt requested or by overnight courier service maintaining records of </font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-12-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">receipt, in all cases with charges prepaid. Any such properly given notice shall be effective upon the earlier of receipt or (a) the date delivered by hand, or (b) the third Business Day after being mailed, or (c) the following Business Day if sent by overnight courier service. All notices shall be sent to the applicable party at its address (or facsimile number) set forth below or in accordance with the last written direction from such party to the other party hereto&#58;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Borrower&#58;&#160;&#160;&#160;&#160;Cumberland Pharmaceuticals Inc.<br>Attn&#58; Chief Financial Officer<br>1500 West End Avenue<br>Suite 1300<br>Nashville, TN 37203-7003</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lender&#58;&#160;&#160;&#160;&#160;Pinnacle Bank<br>150 3rd Avenue South, Suite 900<br>Nashville, TN 37201<br>Attn&#58; Mark D. Mattson, Senior Vice President</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.83pt;text-decoration:underline">Invalidity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If any one or more of the provisions contained in any Loan Document for any reason shall be held invalid, illegal, or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of any Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.83pt;text-decoration:underline">Term of This Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement shall be binding on the Borrower as long as any portion of the Indebtedness remains outstanding or Lender has any obligations to make Advances hereunder, except that each Borrower&#8217;s representations, warranties, and indemnity agreements shall survive the payment in full of the Indebtedness and the termination of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.83pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. No Borrower shall assign its rights or delegate its duties under this Agreement or any other Loan Document. All covenants and agreements made by or on behalf of the Borrower in any Loan Document shall bind such Borrower&#8217;s successors and assigns and shall inure to the benefit of Lender and its successors and permitted assigns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.83pt;text-decoration:underline">Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Lender shall have the right to enter into one or more participation or syndication agreements with one or more participating lenders approved by Lender on such terms and conditions as Lender shall deem advisable. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.83pt;text-decoration:underline">Waivers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As provided in T.C.A. Section 47-50-112, no custom, conduct, action or course of dealing on the part of Lender, its officers, employees, consultants, or agents, nor any failure or delay by Lender with respect to exercising any right, power, or privilege of Lender under the Note, this Agreement, or any other Loan Document shall operate as a waiver thereof, except as otherwise provided in this Agreement. Lender may from time to time waive any requirement hereof, including any of the Conditions Precedent, but no waiver shall be effective unless in writing and signed by Lender. The execution by Lender of any waiver shall not obligate Lender to grant any further, similar, or other waivers. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.83pt;text-decoration:underline">Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement may not be modified or amended except in writing signed by the Borrower and Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.83pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement, the Note, and the other Loan Documents constitute a contract made under, and shall be construed in accordance with and governed by, the laws of the State of Tennessee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.83pt;text-decoration:underline">No Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Nothing contained herein or in any related document shall be deemed to create any partnership, joint venture or other fiduciary relationship between Lender and the Borrower for any purpose. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.33pt;text-decoration:underline">Nature of Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Lender&#8217;s obligation to make Advances shall be deemed to be pursuant to a contract to make a loan or to extend debt financing or financial accommodations to or for </font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-13-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the benefit of the Borrower within the meaning of Sections 365(c)(2) and 365(e)(2)(B) of the United States Bankruptcy Code, 11 U.S.C. &#167; 101 et seq.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.33pt;text-decoration:underline">Governance&#59; Exhibits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The terms of this Agreement shall govern if determined to be in conflict with the terms or provisions in any other Loan Document. The exhibits attached to this Agreement are incorporated in this Agreement and shall be considered a part of this Agreement except that in the event of any conflict between an exhibit and this Agreement or another Loan Document, the provisions of this Agreement or the Loan Document, as the case may be, shall prevail over the exhibit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.33pt;text-decoration:underline">Time of Essence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Time is of the essence with regard to each and every provision of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.33pt;text-decoration:underline">Costs, Expenses, and Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Borrower agrees to pay on demand all out-of-pocket costs and expenses of Lender (including the reasonable fees and out-of-pocket expenses of Lender&#8217;s attorneys, paralegals, accountants, auditors, and consultants) incurred by Lender in connection with the preparation, execution, delivery, administration, interpretation, amendment, waiver or enforcement of this Agreement or the other Loan Documents, or in the protection of Lender&#8217;s rights under the Loan Documents (including any suit for declaratory judgment or interpretation of the provisions hereof and any bankruptcy, insolvency or condemnation proceedings involving the Borrower, its Property, and&#47;or any Collateral)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that with regard to litigation costs, the Lender shall be entitled to recover such costs only in the event that it is the prevailing party. Notwithstanding the foregoing, the Lender agrees to pay indebtedness taxes under Tennessee Code Annotated Section 67-4-409 due upon the recordation of its financing statements. Upon Lender&#8217;s request, the Borrower shall promptly reimburse Lender for all amounts expended, advanced, or incurred by Lender in endeavoring to satisfy any obligation of any Borrower under this Agreement or any other Loan Documents, or to perfect a Lien in favor of Lender, or to protect the Properties or business of any Borrower or to collect the Indebtedness, or to enforce or protect the rights of Lender under this Agreement or any other Loan Document, including all court costs, attorney&#8217;s and paralegal&#8217;s fees, fees of auditors and accountants, and investigation expenses reasonably incurred by Lender in connection with any such matters, and all such amounts shall bear interest at the Default Rate until paid in full. All obligations under this Section shall be part of the Indebtedness and shall survive any termination of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.33pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement may be executed in any number of counterparts or counterpart signature pages (by facsimile transmission or otherwise), each of which, when so executed, shall be deemed an original, but all such counterparts shall constitute but one and the same instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.33pt;text-decoration:underline">Distribution of Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Borrower hereby authorizes Lender, as Lender may elect in its sole discretion, to discuss with and furnish to any affiliate of Lender, to any government or self-regulatory agency with jurisdiction over Lender, or to any participant or prospective participant, all financial statements, audit reports and other information pertaining to the Borrower whether such information was provided by the Borrower or prepared or obtained by Lender or third parties. Neither Lender nor any of its employees, officers, directors or agents make any representation or warranty regarding any audit reports or other analyses of the Borrower which Lender may elect to distribute, whether such information was provided by the Borrower or prepared or obtained by Lender or third parties, nor shall Lender or any of its employees, officers, directors or agents be liable to any Person receiving a copy of such reports or analyses for any inaccuracy or omission contained in such reports or analyses or relating thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.33pt;text-decoration:underline">Jurisdiction&#59; Venue&#59; Service of Process</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. THE BORROWER HEREBY IRREVOCABLY CONSENTS TO THE JURISDICTION OF THE COURTS LOCATED IN DAVIDSON COUNTY, TENNESSEE, INCLUDING WITHOUT LIMITATION FEDERAL COURTS SITTING IN THE MIDDLE DISTRICT OF TENNESSEE AND THE CHANCERY COURT FOR DAVIDSON COUNTY, TENNESSEE, FOR ANY SUIT BROUGHT OR ACTION COMMENCED IN CONNECTION WITH THIS AGREEMENT, ANY OF THE INDEBTEDNESS OR OBLIGATIONS, ANY COLLATERAL, OR ANY RELATIONSHIP BETWEEN LENDER AND THE BORROWER, AND AGREES NOT TO CONTEST OR CHALLENGE VENUE IN ANY SUCH COURTS.</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-14-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.33pt;text-decoration:underline">Jury Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. THE BORROWER HEREBY KNOWINGLY, WILLINGLY AND IRREVOCABLY WAIVES ITS RIGHTS TO DEMAND A JURY TRIAL IN ANY ACTION OR PROCEEDING INVOLVING THIS AGREEMENT, ANY OF THE INDEBTEDNESS OR OBLIGATIONS, ANY COLLATERAL, OR ANY RELATIONSHIP BETWEEN LENDER AND THE BORROWER. THE BORROWER WARRANTS AND REPRESENTS THAT IT HAS REVIEWED THE FOREGOING WAIVERS WITH ITS LEGAL COUNSEL AND HAS KNOWINGLY AND VOLUNTARILY WAIVED ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL. IN THE EVENT OF LITIGATION, THIS SECTION MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.33pt;text-decoration:underline">Waiver of Certain Damages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. IN ANY ACTION TO ENFORCE THIS AGREEMENT, THE BORROWER HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY AND ALL RIGHTS UNDER THE LAWS OF ANY STATE TO CLAIM OR RECOVER ANY SPECIAL, EXEMPLARY, PUNITIVE, CONSEQUENTIAL OR OTHER DAMAGES OTHER THAN ACTUAL DIRECT DAMAGES.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VIII.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.33pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement represents the entire agreement between the parties hereto except for such other agreements set forth in the Loan Documents, superseding any and all other agreements, promises or representations existing prior to or made simultaneously with this Agreement. Any oral statements regarding the subject matter of this Agreement are merged herein.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ARTICLE IX</font><font style="color:#2f5496;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:11.26pt"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DEFINITIONS AND USAGE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IX.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In addition to other words and terms defined in the preamble hereof or elsewhere in this Agreement, the following terms shall have the following meanings herein, unless the context expressly requires otherwise&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a stock purchase transaction and&#47;or an asset purchase transaction of an entity engaged in the same or substantially the same business as the Borrower or which is engaged in a complimentary business to that of Borrower. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Advance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any advance or other extension of credit made by Lender to Borrower under the Note.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Person that directly or indirectly through one or more intermediaries controls, or is controlled by, or is under common control with Borrower. The term &#8220;control&#8221; means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a person, firm or corporation whether through the ownership of voting securities, by contract or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Applicable Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any day, Term SOFR (or, if applicable, the Benchmark Replacement) for a one-month tenor in effect on such day </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;2.75%. Any change in Term SOFR or the Benchmark Replacement shall be effective from and including the effective date of such change in Term SOFR or the Benchmark Replacement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Available Tenor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination and with respect to the then-current Benchmark, as applicable, (x)&#160;if such Benchmark is a term rate, any tenor for such Benchmark (or component thereof) that is or may be used for determining the length of an interest period pursuant to the Term Note or (y)&#160;otherwise, any payment period for interest calculated with reference to such Benchmark (or component thereof) that is or may be used for determining any frequency of making payments of interest calculated with reference to such Benchmark, in each case, as of such date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Bank Product Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all obligations and other liabilities of Borrower to the Lender or any affiliate of Lender in respect of any of the following services provided to Borrower by such Lender or affiliate of Lender&#58; (a) any treasury or other cash management services, including (1) deposit account, (2) automated clearing house (ACH) origination and other funds transfer, (3) depository (including cash vault and check deposit), (4) zero balance accounts and sweep, (5) return items </font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-15-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">processing, (6) controlled disbursement, (7) positive pay, (8) lockbox, (9) account reconciliation and information reporting, (10) payable outsourcing, (11) payroll processing, and (12) trade finance services&#59; and (b) card services, including (1) credit card (including purchasing card and commercial card), (2) prepaid card, including payroll, stored value and gift cards, (3) merchant services processing, and (4) debt service card services.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Benchmark</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, initially, the Term SOFR Reference Rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if a Benchmark Transition Event has occurred with respect to the Term SOFR Reference Rate or the then-current Benchmark, then &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Benchmark</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate pursuant to the provisions of the Term Note.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Benchmark Replacement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means with respect to any Benchmark Transition Event, the sum of&#58; (a)&#160;the alternate benchmark rate that has been selected by the Lender and approved by the Borrower (which approval shall not be unreasonably withheld, conditioned or delayed) giving due consideration to (i)&#160;any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body or (ii)&#160;any evolving or then-prevailing market convention for determining a benchmark rate as a replacement for the then-current Benchmark for Dollar-denominated syndicated credit facilities and (b)&#160;the related Benchmark Replacement Adjustment. For the purposes hereof, any Benchmark Replacement in no event shall ever be less than 1.00%.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Benchmark Replacement Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any replacement of the then-current Benchmark with an Unadjusted Benchmark Replacement, the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) that has been selected by the Lender giving due consideration to (a)&#160;any selection or recommendation of a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement by the Relevant Governmental Body or (b)&#160;any evolving or then-prevailing market convention for determining a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement for Dollar-denominated syndicated credit facilities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Benchmark Replacement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the earliest to occur of the following events with respect to the then-current Benchmark&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;in the case of clause&#160;(a) or (b) of the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Benchmark Transition Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, the later of (i)&#160;the date of the public statement or publication of information referenced therein and (ii)&#160;the date on which the administrator of such Benchmark (or the published component used in the calculation thereof) permanently or indefinitely ceases to provide all Available Tenors of such Benchmark (or such component thereof)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;in the case of clause&#160;(c) of the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Benchmark Transition Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, the first date on which such Benchmark (or the published component used in the calculation thereof) has been determined and announced by or on behalf of the administrator of such Benchmark (or such component thereof) or the regulatory supervisor for the administrator of such Benchmark (or such component thereof) to be non-representative or non-compliant with or non-aligned with the International Organization of Securities Commissions (IOSCO) Principles for Financial Benchmarks&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such non-representativeness, non-compliance or non-alignment will be determined by reference to the most recent statement or publication referenced in such clause&#160;(c) and even if any Available Tenor of such Benchmark (or such component thereof) continues to be provided on such date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;For the avoidance of doubt, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Benchmark Replacement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; will be deemed to have occurred in the case of clause&#160;(a) or (b) with respect to any Benchmark upon the occurrence of the applicable event or events set forth therein with respect to all then-current Available Tenors of such Benchmark (or the published component used in the calculation thereof).</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-16-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Benchmark Transition Start Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, in the case of a Benchmark Transition Event, the earlier of (a) the applicable Benchmark Replacement Date and (b) if such Benchmark Transition Event is a public statement or publication of information of a prospective event, the 90</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> day prior to the expected date of such event as of such public statement or publication of information (or if the expected date of such prospective event is fewer than 90 days after such statement or publication, the date of such statement or publication).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Benchmark Transition Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the occurrence of one or more of the following events with respect to the then-current Benchmark&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;a public statement or publication of information by or on behalf of the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that such administrator has ceased or will cease to provide all Available Tenors of such Benchmark (or such component thereof), permanently or indefinitely&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof)&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof), the Federal Reserve Board, the Federal Reserve Bank of New York, an insolvency official with jurisdiction over the administrator for such Benchmark (or such component), a resolution authority with jurisdiction over the administrator for such Benchmark (or such component) or a court or an entity with similar insolvency or resolution authority over the administrator for such Benchmark (or such component) that states that the administrator of such Benchmark (or such component) has ceased or will cease to provide all Available Tenors of such Benchmark (or such component thereof) permanently or indefinitely&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;a public statement or publication of information by or on behalf of the administrator of such Benchmark (or the published component used in the calculation thereof) or the regulatory supervisor for the administrator of such Benchmark (or such component thereof) announcing that all Available Tenors of such Benchmark (or such component thereof) are not, or as of a specified future date will not be, representative or in compliance with or aligned with the International Organization of Securities Commissions (IOSCO) Principles for Financial Benchmarks.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;For the avoidance of doubt, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Benchmark Transition Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; will be deemed to have occurred with respect to any Benchmark if a public statement or publication of information set forth above has occurred with respect to each then-current Available Tenor of such Benchmark (or the published component used in the calculation thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any day other than a Saturday, Sunday or day on which commercial banks are authorized to close under the laws of the State of Tennessee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;any &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; (as such terms are used in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 13(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">14(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Exchange Act of 1934, but excluding any employee benefit plan of such Person or its Subsidiaries (excluding Cumberland Emerging Technologies Inc.), and any Person acting in its capacity as trustee, agent or other fiduciary or administrator of any such plan) becomes the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">beneficial owner</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; (as defined in Rules 13d-3 and 13d-5 under the Exchange Act of 1934, except that a person or group shall be deemed to have &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">beneficial ownership</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of all securities that such Person or group has the right to acquire (such right, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">option right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), whether such right is exercisable immediately or only after the passage of time), directly or indirectly, of 50% or more of the stock of the Borrower entitled to vote for members of the board of directors or equivalent governing body of the Borrower on a fully diluted basis (and taking into account all such securities that such person or group has the right to acquire pursuant to any option right)&#59; or</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-17-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;during any period of twenty-four (24) consecutive months, a majority of the members of the board of directors or other equivalent governing body of the Borrower cease to be composed of individuals (i) who were members of that board or equivalent governing body on the first day of such period, (ii) whose election or nomination to that board or equivalent governing body was approved by individuals referred to in clause (i) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body or (iii) whose election or nomination to that board or other equivalent governing body was approved by individuals referred to in clauses (i) and (ii) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body (excluding, in the case of both clause (ii) and clause (iii), any individual whose initial nomination for, or assumption of office as, a member of that board or equivalent governing body occurs as a result of an actual or threatened solicitation of proxies or consents for the election or removal of one or more directors by any person or group other than a solicitation for the election of one or more directors by or on behalf of the board of directors).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the date of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Internal Revenue Code of 1986, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any and all collateral securing or intended to secure the Indebtedness, as described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article&#160;II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Compliance Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a certificate substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Conditions Precedent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means those matters or events that by the terms of the Loan Documents must be completed or must occur or exist before Lender would become obligated to fund any Advance, including, without limitation, those matters described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article&#160;IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Conforming Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to either the use or administration of Term SOFR or the use, administration, adoption or implementation of any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#8221; the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">U.S. Government Securities Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#8221; the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Interest Rate Change Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or any similar or analogous definition (or the addition of a concept of an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">interest period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, the applicability and length of lookback periods, and other technical, administrative or operational matters) that the Lender decides may be appropriate to reflect the adoption and implementation of any such rate or to permit the use and administration thereof by the Lender in a manner substantially consistent with market practice (or, if the Lender decides that adoption of any portion of such market practice is not administratively feasible or if the Lender determines that no market practice for the administration of any such rate exists, in such other manner of administration as the Lender decides is reasonably necessary in connection with the administration of the Term Note).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all of a Person&#8217;s obligations, contingent or otherwise, that would be classified on its balance sheet as its liabilities in accordance with GAAP, including, in any event and without limitation, (a) liabilities secured by any mortgage, pledge or lien existing on Property owned by such Person, whether or not the liability secured thereby has assumed by such Person&#59; (b) all indebtedness and other similar monetary obligations of such Person&#59; (c) all guaranties, obligations in respect of letters of credit, endorsements (other than endorsements of negotiable instruments for purposes of collection in the ordinary course of business), obligations to purchase goods or services for the purpose of supplying funds for the purchase or payment of Debt of others and other contingent obligations in respect of, or to purchase, or otherwise acquire, or advance funds for the purchase of, Debt of others&#59; (d) all obligations of such Person to indemnify another Person to the extent of the amount of indemnity, if any, that would be payable by such Person at the time of determination&#59; (e) the principal portion of all obligations of such Person under capital leases (specifically excluding obligations under operating leases), (f) all obligations of such Person to purchase or repurchase any accounts, instruments, chattel paper or general intangibles, and (g) all Rate Management Obligations (excluding Excluded Rate Management Obligations).</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-18-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the occurrence of any of the events specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof, even though any requirement for notice or lapse of time or other condition precedent has not been satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Default Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the rate otherwise applicable under the Note plus 400 basis points per annum. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Dollar</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; mean the lawful money of the United State of America.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EBITDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) Net Income Attributable to Borrower&#8217;s Shareholders, plus (b) to the extent deducted in determining Net Income Attributable to Borrower&#8217;s Shareholders, and without duplication, the sum of (i) Interest Expense, (ii) income tax expense, (iii) depreciation expense, (iv) amortization expense, (v) non-cash compensation expense, (vi) the non-cash cost of products sold associated with the Vibativ Acquisition provided that the inventory was acquired on the acquisition date, (vii) the non-cash cost of products sold associated with the Sancuso Acquisition provided that the inventory was acquired on the acquisition date, and (viii) as reasonably agreed to by Lender, any additional one-time non-cash adjustments as reported by the Borrower on the Borrower&#8217;s quarterly Reconciliation of Net Income (Loss) Attributable to Common Shareholders to Adjusted Earnings (Loss). Through measurement date September 30, 2024, items (vi) and (vii) above shall not exceed thirty percent (30.0%) of EBITDA&#59; and commencing on measurement date December 31, 2024 and continuing for each measurement date thereafter, items (vi) and (vii) above shall not exceed twenty percent (20.0%) of EBITDA. For purposes of calculating EBITDA, EBITDA shall only include EBITDA arising from a permitted Acquisition (pursuant to the provisions of Section 6.12 hereof) if Lender is provided with a quality of earnings report related to any such Acquisition reasonably acceptable to Lender.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all laws, rules, regulations, codes, ordinances, orders, decrees, judgments, injunctions, notices or binding agreements issued, promulgated or entered into by or with any governmental authority, relating in any way to the environment, preservation or reclamation of natural resources, or the management, release or threatened release of any hazardous material.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Equity Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means shares of capital stock, partnership interests, membership interests in a limited liability company, beneficial interests in a trust or other equity ownership interests in a Person, and any warrants, options or other rights entitling the holder thereof to purchase or acquire any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Employee Retirement Income Security Act of 1974, as amended from time to time, including (unless the context otherwise requires) any rules or regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the occurrence of any of the events specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any requirement in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for notice or lapse of time or other condition precedent has been satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Excluded Rate Management Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means, with respect to any guarantor of a Rate Management Obligation, including the grant of a security interest to secure the guaranty of such Rate Management Obligation, any Rate Management Obligation if, and to the extent that, such Rate Management Obligation is or becomes illegal under the Commodity Exchange Act or any rule, regulation or order of the Commodity Futures Trading Commission (or the application or official interpretation of any thereof) by virtue of such guarantor&#8217;s failure for any reason to constitute an &#8220;eligible contract participant&#8221; as defined in the Commodity Exchange Act and the regulations thereunder at the time the guaranty or grant of such security interest becomes effective with respect to such Rate Management Obligation. If a Rate Management Obligation arises under a master agreement governing more than one swap, such exclusion shall apply only to the portion of such Rate Management Obligation that is attributable to swaps for which such Rate Management Obligation or security interest is or becomes illegal.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Federal Reserve Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Board of Governors of the Federal Reserve System of the United States.</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-19-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Funded Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (1) all obligations for money borrowed, (2) all obligations evidenced by a bond, indenture, note, letter of credit or similar instrument, (3) all obligations under capital leases (excluding lease of office space), and (4) all other obligations upon which interest charges are customarily paid.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Funded Debt Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the ratio of (i) Funded Debt </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">less</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the amount of Unrestricted Cash in excess of $7,500,000, to (ii) EBITDA, as determined at the end of each fiscal quarter on a rolling four (4) quarter basis. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means generally accepted accounting principles as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Guarantors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each of Cumberland Pharma Sales Corp., and any permitted future Subsidiary of the Borrower and&#47;or any Guarantor, but shall exclude Cumberland Emerging Technologies Inc.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Guaranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a guaranty agreement executed by each Guarantor in form and substance acceptable to Lender whereby each Guarantor agrees, among other things, to guarantee repayment of the Indebtedness to Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any and all amounts and liabilities of any nature owing or to be owing by Borrower to Lender from time to time in respect of the Loan, whether now existing or hereafter incurred.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Interest Expense</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means interest expense (including without limitation the interest component of any payments in respect of capital leases capitalized or expensed during such period) determined for such fiscal quarter and the prior three fiscal quarters.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Interest Rate Change Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34; means September 5, 2023 and each succeeding first&#160;(1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) day of a calendar month commencing on October 1, 2023, or, at Lender's option while a Benchmark Replacement is in effect, such other dates as are determined by Lender to be appropriate to reflect the tenor of the Benchmark Replacement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Lender&#8217;s Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the office of Lender located at the address set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof, as modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any interest in Property securing an obligation owed to, or a claim by, a Person other than the owner of the Property, whether such interest is based on the common law, statute, or contract, and including, without limitation, the lien or security interest arising from a mortgage, encumbrance, pledge, security agreement, conditional sale, trust receipt or a lease, consignment, or bailment for security purposes. The term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; includes reservations, exceptions, encroachments, easements, rights-of-way, covenants, conditions, restrictions, leases, and other title exceptions and encumbrances affecting any Property. For the purposes of this Agreement, the Borrower shall be deemed to be the owner of any Property that it has acquired or holds subject to a conditional sale agreement, financing lease, or other arrangement pursuant to which title to the Property has been retained by or vested in some other Person for security purposes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the revolving credit facility described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, collectively, all of the agreements, documents, papers and certificates executed, furnished or delivered in connection with this Agreement (whether before, at, or after the Closing Date) or at any time evidencing or securing any of the Indebtedness, including, without limitation, this Agreement, the Note, the Security Documents, the Guaranties, any Rate Management Agreement, and all other documents, certificates, reports, and instruments that this Agreement requires or that were executed or delivered (or both) at Lender&#8217;s request.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Material Adverse Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as applicable, a material adverse effect on, or material adverse change in, (a) the business, operations or financial condition of the Borrower and&#47;or the Guarantors, (b) the value of the Collateral, (c) the ability of the Borrower or any </font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-20-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Guarantor to perform its Obligations, as applicable, under any of the Loan Documents, or (D) Lender&#8217;s ability to enforce the rights and remedies granted under this Agreement or any of the other Loan Documents, in all cases whether attributable to a single circumstance or event or an aggregation of circumstances or events.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means October 1, 2026. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Net Income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Attributable to Borrowers Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means for any period, the net income (or loss) of a Person for such period determined in accordance with GAAP, but excluding therefrom (to the extent otherwise included therein) (i) any extraordinary gains or losses, (ii) any gains attributable to write-ups of assets, and (iii) any income (or loss) of any Person accrued prior to the date it becomes a subsidiary or is merged into or consolidated with such Person on the date that such Person&#8217;s assets are acquired.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Non-Cash Compensation Expense</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means non-cash compensation applicable to employees and non-employees of Borrower, as reflected in a line item depicted on Borrower&#8217;s financial statements and calculated in substantially the same manner as calculated historically, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, in no event shall the amount of Non-Cash Compensation Expense used in the calculation of EBITDA exceed in any period of determination an amount equal to $2,000,000.00.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means that certain $20,000,000 Amended and Restated Revolving Credit Note of even date herewith issued by Borrower to the order of Lender, as such may be amended and&#47;or restated from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Notice of Revolving Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a notice provided by Borrower to Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all of the Indebtedness and all of Borrower&#8217;s and Guarantors&#8217; undertakings in the Loan Documents including, but not limited to, all agreements, representations, warranties, and covenants, and specifically including any Rate Management Obligations (excluding any Excluded Rate Management Obligation) and Bank Product Obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">PBGC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Pension Benefit Guaranty Corporation and any entity succeeding to any or all of its functions under ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Periodic Term SOFR Determination Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Permitted Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (a) liens for taxes incurred in the ordinary course of business not yet due and payable, (b) liens in favor of mechanics, workmen and materialmen and statutory construction or similar liens arising by operation of law or incurred in the ordinary course of business for sums not yet due or that are being contested in good faith or to which adequate reserves exist on the financial statements of the Debtor, and (c) rights reserved to or vested in any governmental or regulatory authority to control or regulate any real property or interests therein in any manner, and all laws, statutes, rules, regulations, ordinances and other pronouncements of any governmental or regulatory authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any individual, corporation, partnership, joint venture, association, limited liability company, joint stock company, trust, unincorporated organization, government, or any agency or political subdivision thereof, or any other form of entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any employee benefit or other plan established or maintained, or to which contributions have been made, by Borrower and covered by Title IV of ERISA or to which Section 412 of the Code applies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Properties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any interest in any kind of property or asset, whether real, personal, or mixed, or tangible or intangible.</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-21-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Prior Loan Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means that certain Revolving Credit Loan Agreement dated as of July 31, 2017 between Borrower and Lender, as most recently amended by that certain Ninth Amendment to Revolving Credit Loan Agreement dated as of September 29, 2022. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Rate Management Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any agreement, device or arrangement providing for payments which are related to fluctuations of interest rates, exchange rates, forward rates, or equity prices, including, but not limited to, dollar-denominated or cross-currency interest rate exchange agreements, forward currency exchange agreements, interest rate cap or collar protection agreements, forward rate currency or interest rate options, puts and warrants, and any agreement pertaining to equity derivative transactions (e.g., equity or equity index swaps, options, caps, floors, collars and forwards), including without limitation any ISDA Master Agreement between Borrower and Lender or any affiliate of Lender, and any schedules, confirmations and documents and other confirming evidence between the parties confirming transactions thereunder, all whether now existing or hereafter arising, and in each case as amended, modified or supplemented from time to time, and shall include but not be limited to the Rate Management Agreement and all schedules, confirmations and documents confirming transactions thereunder.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Rate Management Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any and all obligations of Borrower to Lender or any Affiliate of Lender, whether absolute, contingent or otherwise and howsoever and whensoever (whether now or hereafter) created, arising, or evidenced (including all renewals, extensions and modifications thereof and substitutions therefor), under or in connection with (i) any and all Rate Management Agreements, and (ii) any and all cancellations, buy-backs, reversals, terminations or assignments of any Rate Management Agreement.  Rate Management Obligations shall specifically include any obligation that constitutes a &#8220;swap&#8221; within the meaning of section 1a(47) of the Commodity Exchange Act, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Relevant Governmental Body</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Federal Reserve Board or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Federal Reserve Board or the Federal Reserve Bank of New York, or any successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Sancuso Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Borrower&#8217;s purchase of certain assets related to the manufacture, marketing and sale of the proprietary oncology-supportive care medicine, Sancuso, from Kyowa Kirin, Inc.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Security Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each Security Agreement executed by the Borrower and the Guarantors in favor of Lender of even date herewith, as such may be amended and&#47;or restated from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Security Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any and all instruments creating, evidencing or providing security at any time for the Obligations, including, without limitation, the Security Agreements, Stock Pledge Agreement, and all UCC financing statements filed in conjunction therewith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a rate equal to the secured overnight financing rate as administered by the SOFR Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SOFR Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Stock Pledge Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means that certain Stock Pledge Agreement entered into by the Borrower in favor of Lender of even date herewith, as such may be amended, together with all stock powers and Regulation U forms, as may be applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at the time as of which any determination is being made, any corporation, partnership, or other entity of which more than fifty percent (50%) of the issued and outstanding voting securities is owned or controlled, directly or indirectly, by any Person.</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-22-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any day on or after the then most recent Interest Rate Change Date, the Term SOFR Reference Rate for a tenor of one month determined on the day (such day, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Periodic Term SOFR Determination Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) that is two (2) U.S. Government Securities Business Days prior to such Interest Rate Change Date, as such rate is published by the Term SOFR Administrator on such Periodic Term SOFR Determination Day&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, however, that if as of 5&#58;00 p.m. (New York City time) on any Periodic Term SOFR Determination Day the Term SOFR Reference Rate for the applicable tenor has not been published by the Term SOFR Administrator and a Benchmark Replacement Date with respect to the Term SOFR Reference Rate has not occurred, then Term SOFR will be the Term SOFR Reference Rate for such tenor as published by the Term SOFR Administrator on the first preceding U.S. Government Securities Business Day for which such Term SOFR Reference Rate for such tenor was published by the Term SOFR Administrator so long as such first preceding U.S. Government Securities Business Day is not more than three (3) U.S. Government Securities Business Days prior to such Periodic Term SOFR Determination Day. For the purposes hereof, Term SOFR in no event shall ever be less than 1.00%.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Term SOFR Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means CME Group Benchmark Administration Limited (CBA) (or a successor administrator of the Term SOFR Reference Rate selected by Lender in its reasonable discretion).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Term SOFR Reference Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the forward-looking term rate based on SOFR.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">UCC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Uniform Commercial Code as adopted in the State of Tennessee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Unadjusted Benchmark Replacement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the applicable Benchmark Replacement excluding the related Benchmark Replacement Adjustment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Unrestricted Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, on any date of determination, the aggregate amount of all cash of the Borrower and its Subsidiaries held with Lender, not subject to any Lien or restriction (except for Liens or restrictions in favor of, or imposed by, Lender). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">U.S.&#160;Government Securities Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any day except for (a)&#160;a Saturday, (b)&#160;a Sunday or (c)&#160;a day on which the Securities Industry and Financial Markets Association recommends that the fixed income departments of its members be closed for the entire day for purposes of trading in United States government securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Vibativ Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Borrower&#8217;s purchase of certain assets related to the manufacture, marketing and sale of the proprietary antibiotic, Vibativ from Theravance Biopharma Ireland Limited and Theravance Biopharma US, Inc. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IX.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">Computations&#59; Accounting Principles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Where the character or amount of any asset or liability or item of income or expense is required to be determined, or any consolidation or other accounting computation is required to be made for the purposes of this Agreement, such determination or calculation, to the extent applicable and except as otherwise specified in this Agreement, shall be made in accordance with GAAP consistent with those in effect at the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IX.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">General Construction&#59; Captions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. All definitions and other terms used in this Agreement are equally applicable to the singular and plural forms thereof, and all references to any gender include all other genders. The captions in this Agreement are for convenience only, and in no way limit or amplify the provisions hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IX.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">UCC Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Terms used in this Agreement that are defined in the UCC shall have the same meanings herein, except as otherwise expressly provided or amplified (but not limited) herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IX.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.15pt;text-decoration:underline">References to Documents and Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. All defined terms and references in this Agreement with respect to any agreements, notes, instruments, certificates or other documents shall be deemed to refer to such documents and to any amendments, modifications, renewals, extensions, replacements, restatements, substitutions and supplements of and to such documents. Unless otherwise provided, all </font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-23-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">references to statutes and related regulations shall include any amendments thereof and any successor statutes and regulations.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment and Restatement of Prior Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement amends and restates, in its entirety, the Prior Loan Agreement, and the Obligations outstanding thereunder shall be deemed to be outstanding under this Agreement.  Nothing in this Agreement shall be deemed (i) to be a repayment or novation of the Obligations, nor (ii) to release or otherwise adversely affect the Collateral or any rights of the Lender against the Guarantor. Any reference to the Prior Loan Agreement in any other Loan Document shall on a going forward basis refer to this Agreement, as such may be amended and&#47;or restated from time to time.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;signatures commence on next page&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-24-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ENTERED INTO as of the date first written above.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">BORROWER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CUMBERLAND PHARMACEUTICALS INC.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#47;s&#47;A. J. Kazimi&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A.J. Kazimi, </font></div><div style="padding-left:216pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LENDER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PINNACLE BANK</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Mark D. Mattson</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mark D. Mattson, </font></div><div style="padding-left:216pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Senior Vice President</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Signature Page to Amended and Restated Loan Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Guarantor Acknowledgment follows&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div><font><br></font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-25-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GUARANTOR ACKNOWLEDGEMENT</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The undersigned Guarantor joins in the execution of this Agreement to acknowledge and agree that the Guaranty and the Security Agreement (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Guaranty Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), each dated as of July 31, 2017, remain in full force and effect and all obligations evidenced thereby continue to be binding upon Guarantor, subject to no defense, counterclaim, or objection. The Guarantor further agrees and acknowledges that any reference to the Prior Loan Agreement contained within the Guaranty Documents shall be replaced with reference to this Agreement, as such may be amended and&#47;or restated from time to time. </font></div><div><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CUMBERLAND PHARMACEUTICALS INC.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; A. J. Kazimi</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A.J. Kazimi, </font></div><div style="padding-left:216pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">President</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-26-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SCHEDULE 3.18 </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">COLLATERAL LOCATIONS, LEASES, <br>AND STORAGE AGREEMENTS</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cardinal Health SPS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">501 Mason Road, Ste 200, LaVergne , TN 37086</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-27-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A<br>COMPLIANCE CERTIFICATE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">QUARTERLY COMPLIANCE CERTIFICATE</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58;&#160;&#160;&#160;&#160;As of the Quarter End&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To&#58;&#160;&#160;&#160;&#160;Pinnacle Bank (&#8220;Pinnacle&#8221;)</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This certificate, which is duly signed by a senior officer of the Borrower certifies that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a)&#160;&#160;&#160;&#160;Borrower is&#47;is not in full compliance with all loan agreements, promissory notes and other loan documents between Borrower and Pinnacle. If not in compliance, summarize below or on a separate attached page. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">b)&#160;&#160;&#160;&#160;The attached covenant calculations are&#47;are not accurate and are&#47;are not calculated in accordance with the loan agreements. If the response is negative, the following financial covenant violation(s) exist(s). If not in compliance, summarize below or on a separate attached page. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Summarization of violations or other&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cumberland Pharmaceuticals Inc.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Financial Covenant Compliance Certificate follows&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-28-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FINANCIAL COVENANT COMPLIANCE CERTIFICATE</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Calculation Date&#58; _______________</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Funded Debt Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;Funded Debt, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">less</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the amount of </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Unrestricted Cash in excess of $7,500,000</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(Numerator)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Divided By</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;EBITDA </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;Net Income Attributable to Borrowers </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Shareholders&#160;&#160;&#160;&#160;$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;Plus&#58; Interest Expense&#160;&#160;&#160;&#160;$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;Plus&#58; Income Tax Expense&#160;&#160;&#160;&#160;$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;Plus&#58; Depreciation Expense&#160;&#160;&#160;&#160;$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;Plus&#58; Amortization Expense&#160;&#160;&#160;&#160;$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;Plus&#58; Non-Cash Compensation Expense&#160;&#160;&#160;&#160;$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;Plus&#58; non-cash cost of products sold&#160;&#160;&#160;&#160;$_______________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Associated with the Vibativ Acquisition</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;provided that the inventory was acquired </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;  on the acquisition date (subject to caps</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;  set forth in the Loan Agreement)</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;           Plus&#58; non-cash cost of products sold&#160;&#160;&#160;&#160;$_______________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160; associated with the Sancuso Acquisition</font></div><div style="padding-left:36pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> provided that the inventory was acquired </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160; on the acquisition date (subject to caps</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160; set forth in the Loan Agreement)</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;          Plus&#58; any additional one-time non-cash &#160;&#160;&#160;&#160;$_______________</font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;adjustments as reported by Borrower on </font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Borrower&#8217;s quarterly Reconciliation of </font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">     Net Income (Loss) Attributable to Common</font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">     Shareholders to Adjusted Earnings (Loss). </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.15pt">Equals&#58; EBITDA (Denominator)&#160;&#160;&#160;&#160;$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ratio of Numerator to Denominator (Funded Debt Ratio)&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Calculation shall not exceed 2.50 to 1.00, all as calculated on a rolling four quarter basis</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-29-</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4877-8544-3701.5</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cpix-20230905.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:8cc30226-89a6-4c73-9ac2-669e1e710de4,g:6b0b6ef1-9ebe-4b40-895e-243bdae26558-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cpix="http://cumberlandpharma.com/20230905" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://cumberlandpharma.com/20230905">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20230905_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20230905_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformationDocument" roleURI="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument">
        <link:definition>0000001 - Document - Document and Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cpix-20230905_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:8cc30226-89a6-4c73-9ac2-669e1e710de4,g:6b0b6ef1-9ebe-4b40-895e-243bdae26558-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_2ede9f8f-249d-4e3a-ac67-7d3f92012f1a_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_1ad1c6de-8b9e-4317-aed6-8ecf8d37c56e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_6c109ea9-17a2-4094-a3d4-a844e1a6b121_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7e7787f2-02f7-4e31-8881-d2eeefe1cbd9_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_cb1113f9-efda-4455-b989-8111ec594b29_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_0c4d84c9-5d8c-48c5-8bcc-390e7008b604_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_f4142cca-235c-464c-bd5c-e3940235fcce_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_0d178a6d-d36c-41a6-816f-06f6dccaa758_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_6812256b-f358-4ad6-87f5-c6d100562c67_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_19a76db8-3b3b-4d1d-8621-d442be98bb73_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_67179645-e6eb-48b1-97a0-cca1bd70ed19_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_9dd417a1-35e1-4eae-bcf7-c938b198d8b6_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_b59e0cc8-4c6f-4b12-bbf3-0e7ac510e767_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_7abb188d-73a1-4733-ac63-616e16269e0a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_1ed8c348-501c-4687-996b-eff0ee5c6325_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_b2cd11ae-9ea5-4a1f-9eb7-c0a48d0cc0f7_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_1e428d15-a2e6-49e2-b623-84cfcdd607e7_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3f33f03c-9abb-46ab-a80e-3ab84ccbc32e_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_0205205c-38df-4249-b86c-89ecddf425a2_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_c306ac9a-254a-43db-8dce-7c1a7309f167_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b73a6603-45ac-444d-8ad7-0b74d0308d58_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_3acfee90-4bbb-455f-80b1-1f486d4b43d4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ca71a019-e0c1-4cc1-8edc-26b4d21fdb86_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cpix-20230905_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:8cc30226-89a6-4c73-9ac2-669e1e710de4,g:6b0b6ef1-9ebe-4b40-895e-243bdae26558-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="cpix-20230905.xsd#DocumentandEntityInformationDocument"/>
  <link:presentationLink xlink:role="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e445f5a8-78c6-49aa-9b55-0559cfebeeb9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_DocumentType_e445f5a8-78c6-49aa-9b55-0559cfebeeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7c2fe623-af06-496b-9040-8b2bd33ca5ab" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_DocumentPeriodEndDate_7c2fe623-af06-496b-9040-8b2bd33ca5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e04069a7-0739-4dfd-8a6b-3a46632eb914" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_EntityRegistrantName_e04069a7-0739-4dfd-8a6b-3a46632eb914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0a0057dd-7d3c-4119-8e24-b42948e539a2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_EntityCentralIndexKey_0a0057dd-7d3c-4119-8e24-b42948e539a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d1696ada-38bd-4c65-833f-27ba4767d83a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_AmendmentFlag_d1696ada-38bd-4c65-833f-27ba4767d83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8264aebc-a70a-40f7-a8b6-7c0e1b58fbc1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8264aebc-a70a-40f7-a8b6-7c0e1b58fbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4b2c6d68-390d-489f-bb45-0accf60ec531" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_EntityFileNumber_4b2c6d68-390d-489f-bb45-0accf60ec531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_1c5b0e64-9ffd-45a7-861c-e319b637090b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_EntityTaxIdentificationNumber_1c5b0e64-9ffd-45a7-861c-e319b637090b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_80c77644-26a5-4ee7-b96f-eca97d19b6c6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_CityAreaCode_80c77644-26a5-4ee7-b96f-eca97d19b6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_d644be98-7b47-467d-97a3-b4e896bfd07d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_LocalPhoneNumber_d644be98-7b47-467d-97a3-b4e896bfd07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_174dca5b-37fa-4bf0-a88e-55f20df4feeb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_WrittenCommunications_174dca5b-37fa-4bf0-a88e-55f20df4feeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_90e37a99-fab3-4863-bd12-6be36bdf10fb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_SolicitingMaterial_90e37a99-fab3-4863-bd12-6be36bdf10fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_1ff7d83b-7529-4d9c-b72c-f2b3c89c81d3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_PreCommencementTenderOffer_1ff7d83b-7529-4d9c-b72c-f2b3c89c81d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_2001c3b7-fe07-4854-a164-bb9448d90e79" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_2001c3b7-fe07-4854-a164-bb9448d90e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_3cc1accf-062f-4a2a-a699-db2dc7f4a67a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_Security12bTitle_3cc1accf-062f-4a2a-a699-db2dc7f4a67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a05914fa-40b1-4109-befa-140c94070908" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_TradingSymbol_a05914fa-40b1-4109-befa-140c94070908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_9ee453a7-fedb-4c60-baba-55cb2ebd2e82" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_SecurityExchangeName_9ee453a7-fedb-4c60-baba-55cb2ebd2e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_89b6006b-4089-4f84-a141-4ff06094bf5c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_EntityEmergingGrowthCompany_89b6006b-4089-4f84-a141-4ff06094bf5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_91bd9170-d769-49cc-88a6-409e57df12c5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_EntityAddressAddressLine1_91bd9170-d769-49cc-88a6-409e57df12c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_bb6ad2d2-b503-4752-99f6-a9244574cfc4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_EntityAddressPostalZipCode_bb6ad2d2-b503-4752-99f6-a9244574cfc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e24de609-8470-41af-98b9-6a329d256002" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_EntityAddressCityOrTown_e24de609-8470-41af-98b9-6a329d256002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b8a048e8-9f67-41b1-8e0b-dcdc557aee06" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_337c9eb1-5e14-41bd-94ae-b7910ccac441" xlink:to="loc_dei_EntityAddressStateOrProvince_b8a048e8-9f67-41b1-8e0b-dcdc557aee06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140011519577344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document<br></strong></div></th>
<th class="th"><div>Sep. 05, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  05,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CUMBERLAND PHARMACEUTICALS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001087294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">62-1765329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">255-0068<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CPIX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1600 West End Avenue, Suite 1300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Nashville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>cpix-20230905_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cpix-20230905.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier>
        </entity>
        <period>
            <startDate>2023-09-05</startDate>
            <endDate>2023-09-05</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001087294</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2023-09-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">CUMBERLAND PHARMACEUTICALS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">TN</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-33637</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">62-1765329</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">1600 West End Avenue, Suite 1300</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Nashville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">37203</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">615</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">255-0068</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">CPIX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M7>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    "  'GR57)!Z;HJT
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M2P$"% ,4    "  'GR57!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (  >?)5?I"B7_[P   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M  >?)5>97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ !Y\E5R4IOE)E!   JQ   !@
M     ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M  >?)5>?H!OPL0(  .(,   -              "  :D,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ !Y\E5Y>*NQS     $P(   L              ( !
MA0\  %]R96QS+RYR96QS4$L! A0#%     @ !Y\E5QPX9>H_ 0  / (   \
M             ( !;A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (  >?
M)5<D'INBK0   /@!   :              "  =H1  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (  >?)5=ED'F2&0$  ,\#   3
M          "  ;\2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(   D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cpix-20230905.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cumberlandpharma.com/role/DocumentandEntityInformationDocument</Role>
      <ShortName>Document and Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="cpix-20230905.htm">cpix-20230905.htm</File>
    <File>cpix-20230905.xsd</File>
    <File>cpix-20230905_lab.xml</File>
    <File>cpix-20230905_pre.xml</File>
    <File>cumberlandpharm-arloanagre.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cpix-20230905.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "cpix-20230905.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cpix-20230905_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cpix-20230905_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cpix-20230905.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cpix",
   "nsuri": "http://cumberlandpharma.com/20230905",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cpix-20230905.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Document and Entity Information Document",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument",
     "shortName": "Document and Entity Information Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cpix-20230905.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001628280-23-031458-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-031458-xbrl.zip
M4$L#!!0    (  >?)5?Z[YCE2Q$  %!W   1    8W!I>"TR,#(S,#DP-2YH
M=&WM'6ESXCCV^_P*+;,[DU3%QC97( E;-*%[V.E.LI"NGMHO6\(60=/&]LAR
M$O;7[WN2S4TX.@?ISGR8 )*?].Y#3^[3?]X/?7++1,S#X"QGFU:._+-^^C?#
M^.-=YR,Y#]UDR ))FH)1R3QRQ^6 R $C7T+QE=]2<N53V0_%T##44\TP&@E^
M,Y#$L9Q"-BL=%+5CURU8CE,VCJNT;!3=2L&H4M<QRN4JLUG%MCQ6/+JIE7M6
MK\SZME%E/684>T4+'B@QPRD6>AYE3KE4.C[R:I;E4*_2+UFL8A49\WK]DM,_
M+L(:GNVY\! L.Y" '^ 8Q#5^+\]R RFC6CY_=W=GWO>$;X;B)L\#GP<,$<Y+
M08,8\:$2")(')"S#<@S;R8V!+(?A6'9A"E V'<?YJB<L?"*6-'#9!+PT8N;.
M/ '?S9OP]L%MVB7#.C8*]GC=>';5NT*VIIW_X]/'KCM@0VK,K^ZQR5-JG]G2
M,("T*&0382-?'\ *AWLTSN NVXE=K5;S]\B=\987@,Y,Q5$UM>;3X.8LQP+C
M<S<'#&;4JY\.F:0$'S787PF_/<LUPT""X!K7HPBVX>IO9SG)[F5>K9JO__33
M3Z>22Y_5W8C?&XB?5;5*IWG]XVE>@^Z%WJA^ZO%;$LN1S\YR'H\CGXYJ01@P
MV "_K^%$)O1'[GDL4!]A_ *T1W!7KW\O.ZQ_EG,-X%) APB)\5HK@.5&3=B=
MH'X[\-C][VR4(]P[R_4-Q\G5+>"9=5QQJL73_ S4+19I@!)[J,CO?7HS!E[(
MU?O4C]D"W/PL(H+UF6 @)_$2^B-?:K&2)UB9*#[5)%#]+!?S8>2C$*C?!D)M
M;)K4YGWL 8C\+ R]_F31= ]QF CU3>E4+<56X8+89K\S1<_L&_?P>Y\S011\
MME2SFNW?9^D\_W ]^VD6>@3D"KWL&^B2D.=@)NN(GV%5#12F^;'Q-KT54[.1
M['NV2'X&[XQ(8ZKDI^0P#]*J11:IP]?9R?\B]2;/I&(^Y($Q8&C+:T[5=$J1
M/+GCGAS4;,OZ1TY-K9_&$049Z8D\ -"?-9P%:+AG@_K\)JBY0$0F (*D/9]E
M$WJA@+T;;NC[-(I9+?MPDJF;-G^&>NAD2,4-[*\72AD.:[@W\&&2N]1/%U'K
MZ>')MDU+;UT"C:27K9P.FVHH+[W%L>JQ6;56#UNF/1[+*]@BFY 2$#:84\\!
M5DBFLQR8TEG$4U2<2)(X]+E'?K;4?R<1]3P>W-0L8BLHDV7RBA8;$AN7S<9A
M%Z&H90OT0:*,/AUR?U3[]9H/0<TOV!WIA$,:_'H4@Z<!ER1X7T^,^?]8S3X&
MBJNO=QK!"L!1[$D1MBM%(,GGB_9UZYQTKQO7K>ZL@.S7;AUD;K?5_-QI7[=;
M7=*X.">M/YJ_-2X^M$CS\M.G=K?;OKQX012*ZU H(L&_T'@ LB+#X(B<FTT3
MHK!2L;K/E%?;?G_9^40V]V995*I]NW9F8,*.C=_G/1E9B7IJ0&08U6S0JTS+
M#)_U85?6\=1/0N]4_;8AQ9R"W7=VHYBSD:R"I'9:%]>DT[JZ[%QOA.4>[?XJ
M$7%"(:V0(>DR%V-88A?(98?8I0/OD(1]<@TY!@PE@DL."[?NW0&$'8PT7(G#
M=K50W%JLESFJ9]6&>>H4E]LA%DDV[$'(4CK2:=3!]KIQI:*&EHXE<D3G"A +
MW,N:![\80P QP,<,CXZ,$:/"8,$X,ERRB7G5.MQ[.B+F*"L=%H5"D@,O_0ZX
M^B!3DK!;3&V%&F;>(D)[(C6;V=!M,XX.N^$QYI'R D8RSA?0M'QZU^I\1!=X
M]5NC\ZG1;'V^;C<;'[ND?=$T-S>QSR\'RREST+JG8#60 ,A^,4:<T)C$$7,Q
MQ/<(#PB7,0$[ ](@5HOWE$TMK;"IKR:P+51,JU39*+#=!JQMF96B\UK *B)4
MMXGN5X7R6:CN1/=DSM]B7#'/2LW%W#+I2OF_$)DX.A&;#4W2'Y]>WZQU^J:E
M<$M+U [<4( -5K6LK@0KW0R30(I1,_1F71>6QC"5EBP2X2W"F?BL8JY^S8*
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M[H_4D^D#80\(0;.H#P>FRD$)P!&$!J-LK!_ZL#@^A^:68T 3DP.PK^0#"Y@
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MS*D/O\IZ?\K5>?T/A*I_5;3^?U!+ P04    "  'GR57[IR@\H8"  #=!P
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MM^0MY TB)0U=-,?S=F&]2ML*?8>V$QP>CO#F>V_,G6"S.Z:]/U!+ P04
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MT4/$W+179Z)[%/ZGL^)!8K$U$0<B;EU6?O]TB,UFC%BUS0C(W8<%S9W/T.L
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M8$ M<0G*#+[![%(L 6!)I4Z=_+26#T3]8*XS%9 ;!;^=2[5C;50:'Z+F][X
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M\4-Y3WR$8?&<?>4YE)QDFZWM\+&>\SGUCCSG["3%X,V244DP3=PV<YY-0QW
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MG(@)XKL;D(V0ND7"I2JD%H*\;%H"6[^5[MNSE58;\*=Y5A0'!J"=<E$K$]O
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ML\9A8P[XA,$K"/E$M8]EBHQWF8"'7 6IP0CQS0=9-)7KN1JYHM:2;CK?-]U
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M%GUN(M=.LA 3OBG<AG>FDMJ TW0):BR,'@3Q)H";(<N6>(Y#RV%HSN)T#A
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M&"K D9J%@X)[U8<B:QGMS_3];6"]"8H1J7$*NA7&SZ.WWS%M5BFO2_I]3/A
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M8XMKZ&RT?2^EE "><#S[A/EU$+9(P.1WA'BRF 2A$M;^O1=R/RY3<N\Z,<V
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M=PG)(N;-XPBBHRE,S9.<FTNXY4J59B:Y/??Q.]WQ5+J#U\2D\*\H?MR>DY#
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M0E*%AD]2.+/XUAK,C^ABC<N@7O;!(P65O^)%.&@_KK^11F=A!'F@"*H*DVQ
MS-B''GE/P0WG2#=CHH,(@SNE$L Z@>YB['_!HY@;"Q2;$7F6J"(/ ^[AODX9
MRXT(#5Z#4<_TGK&-!7#V3"<:H6$M\\R]1&FBU@2]/(9NT[3I;AR26]!/XCBD
M1<1Q<QXIU%C0IL?VYW'P]/"T-(-CVK[\NB^RTTM/J)>*5O!CUPJ38$'CJ$+H
M4V@MP%J;FO^_O6M_3MO8PO_*3MO;@1F9:SMQ'C<SG9$Q26@(=@&G[4]WA!"V
M&B%1/2#TK^^>LT^!L'$L@\";F9#8@+2[.GOV/+_/(G\!D2V9"8 ]0>Z''[R#
MGH9]#7EOU"^Q=0<*/2"IQ6Z(]9<W5$O]PZ^IY-(2)1G4APE=W"S3"' BH+4]
MR88P^H0WY;,>.U'"@6*/-2<0QD-#UHAR::(<5*FW 5T5034SY(Z-;*>9TK$2
M"+-2!U<47T\<*IG8)V/E#A+4V)"<16_FUIEYK*MF0D\8*Q>/$]Y[S.)T ^S*
M:7_!_ 2X/[G+BH#8RY-357,XXN#@IN>F1+GDAVH59+,:U<-\1:B456%-BCMB
MX>>O/H-?U,TBK"90G:Q@-EF0Z ,2RX!5$OO?Q!9V0H9NS\PI_I/!K"ZC3O?$
MU.D:S.HM:RVH9,+@NRS.K8[^RN665U+'^5$35D[EH,_U:Q8L. _RR6MJ6:1S
M,"YR-H66.IY$O,<]3 %]E">/AXO\_;L^8,Y@5AOO1XV.APQ)806=OL7ZTU-3
M?UJ:&*_M<:N.+#/?2K;>C;P99]S*=:%C1EJ0=4N$,QY\B3V=>7H<9&Z:B8:=
ML3KH8]:UYPD6&?XSO>(<V"GXCY$D*YW&/O+NWI-S&T'S3GQ$I2W"@#@S\-TX
M2I(CSO*WR ]"#4'/U8EQR.\4?BI_(=>9LL))& *L4LH-_:(+LV^(JVM1'_9.
M)* 5IAFO5%,DK"(?HT ]IVSW\Y0,7S&J./P96B_4RZ8/UW%%?K!QT[ D":Q<
M8=BCWQC'C*7N[^*/XR#"ABDV-S8@/I.DKG-$%0#DP5#;_0N;BC[RZBC-<X?*
MDX[^>.P'"%.E%]+P!4A<ZL"QF!=UU<9^/'$4/(1L%-7B7OQ3,%!!&R '@2@1
M#MK&^N=R2Z<HC5AV]W[@2!XA%5VI#'8-FD4T<E-+P0!A$)2Z@;@^Q;2G&)_%
M +(@H!?[8.AI6P'GLU;CR!#BADMX_X(TB#DHGNJ@J&:EA8;=JO-::!466ID2
MW\YVT7:675/<<T)1A*W$>Z-4T3W<[S::)Y$WX]J"?C?D/];TW:AOPCH 7#C8
M<R^W(_93">(0#> 39D-5LC=W CR=4I8@9_N!;5-7YS?#T#F'2P:*-?4.58]U
MT<'&P)67V_I%PX!8Q;6[574 Y+_@0EP_D*'^8;8X&CKN5TP!0"LMSD%+#2?<
MC>:(2#+PO_;&=%/?56G"U%!!F0HG]UYB-%,\=%#>QO<9G#="L&!5>*I(9(V!
M+4W4CSFUEZ_KJ[1[.A'=W9S1)K)6FH;R F\&58<?])S1>32J1*Q-U;<4LK$1
MW@F^\B840$$I.AW-GU'\56"N 8UC"JCE@JXQ@%J8$36(N'49A3,O%,Y8*3<-
M>9E-DK"OQ5X:&>DM2WK[5&]F2405!K5\6=BN.F*[4IXXS6*JX%BZ7+CYO+-*
M<[10:3IA-J:F&:;E +75XXAH(X8WQE4G@W[U4FS]"F&6-XLC,#N!H7(&?DP,
M"GA$93VD%^*K93%]^FD1S1WRR8\!GL$02)0IE0(J1YW[U9%*]%M61YBCDUA&
MW5B"V\@5H@BSL*BGPG1*5$P@JX?'E3.#=; GM/31PL_#7*F8E8(4U3"QQOQT
MSH%1;(!S6K!GJ<+$$H<KA# M K*Z;C8UO$>M"(GZ1A( ["]>1<M.?[B_$>S2
M!+L:-9ZRTX>%(45#(K:=(HTZ-1J1>)I^4Q,8_#2X.2/JU_D04E/J%\N!;?Y&
M#+5;1FK*E)K\VE9'AC;Q+! PP-'\"D>?BS .[Y.\NA&HT@2J\)RHDE!IB<7B
MP1(L11"H$<LVX&,-/B -NV$Q/0R88;0)QS%EH"6L:U=4NY)KK/!C,%+B2A)H
MP,AM:7(KD4,J(ZN6H*- :X[ELGD^,EPL80  Z#W6DK,R/OC ^EI763?(FY_D
M=2=1[#'4_;$_3A%QP$5PUK/C_\@@)6\.QP14E@*T!)J@LRC5+%%(.-$Q ;RX
M""=!G7@ \C_R8\^%?#]&D,5/6'NH$%],65,994VGIJS)E#4]VWXSH48%X!:R
M685Y5&GZ-]3+D,A:ZC/F'*L&Q9XW]F+,MN,G\2:*:"H*/<Z5I2%U28"I!:FA
M:3 "_@CX506>W)[T8-8Y.P4UY>81J9W6R76CW]!R-B)^ 4?0N>C$HF-/%'@8
MKOT=#UI8;NB5^A"M%H7UW!I42V3G_8U08H;=NY8__WCV]EU%X2VJ@+%D058<
M4KX6?^)C;@.=T95[\^[XF$P;DP:I25>PB3UI= AUPBMT-GD,]^]JQ'32L+UP
MBT,G,*M/H?IC8_G :-D:_CL0/>82"$Y-'C=9.S@QALAE+8D6TV;J\W.?T;[<
M.T446C8QYV'BSIH/XP0JZ*@"15-PPPV)=V:&)]Y_TQ'.'S+$)"(!\#:++?V]
M8_794BL+F3&0UEY\M_[91#@+N'Y$$YCZUBH*&9:.0.44$D_#:$\:=$\9;[%T
M*Z>JL;/FYQ;Y$$?95%,VVE!!O#J\K*[6/+?KF\71UN[0Q./XA8J3$SI\,9OK
M0"\+*,Z1G[BQA]@L1A++E\3\(ZF.*.()P<IJCX(H^HKUEC!JM*XD51_,P8A%
M66)QW:P8*,]UZ&.G,I2X>3$B%;#^4,CY1--4 2KT4UY*.?!".#L]$^4L3RQ"
M9P2K0E>[T BMELQH1G>QR9P#MY:%0\6?M7'BANJY7'$2))=TV0'HMC+R8PD7
M<,2522Y<;G&2,\9-H2/V<MJ+VR+"';1G9)[ 1UL\X##BHNP;? 2='Y..H,-I
M8S4^4(2S\Z:,L141?)8^D*LKPH"]/P'S?X0TN>QF==/%5IX@4Q?NYQ]/7AV_
MN]^/JXR,RYBF)DPUI\[FX9 ^4(%@@+$V5+_,0HR"QH $)'[)XZ*<?%55 ,',
MV^&(2DO,"I/>2Y2ASUB(F1!;X:1  !4.]W DZ>D@-/ -3W8$]Q]YD(:25?JP
MG2;8F G)*^(&*. BX@*YJ9C%2K$C3^>ZC1U4^G2/4+,"= _:#(D&JJ+EH8RZ
M+VN7?/&'D&$S)<:P&U)_Z .8L47$LF#5YN#6BYT9,G&<^]'TUHDG#FG##:$-
MD+O<\/_"#U[W6?WQEC3[R1,_H?8?C=,=!KBGS@CTQ%'@C>EO7C5.SL1J%4>]
M :4_XT"V+#IONRY8!B -5S'58OXTV"W*2(/\#@% QAE 989*+6]$4R8,5)&"
MG"-!BX2L AL"*"6P7QG5,;2+<2H"/Q'LH8(<7&6M9/.&(D_AN'F<RUNMD:L6
ML."24)H@U?M=W.4L-9:+A4()@:)(L,3.Y0PVFJ. ).KL/(1L@>RR6T+J7+JA
MX$?'(:[AT\'Y0VDBO2%GL(V0,T=0/_(C3^>IW=+9LX5]O$.8\P?OXP]>B$6#
M30WGD>WGIC/=><=I@]A4V!10K-[+#2*?:,0@.>8^Z&#!@EJ RLAQS6"-(UVA
M#'KT$3$SR& !L'),X<:)6NU81 H3X:/<B)@M;W24S,3LC:0!QQ6TS4OGI&!L
M8]DVYF,8,@J159KUB(<1F5-3#FO-F;ZB$Q@OQ,'*(.Z2[5*/;V';O-RC;0,E
M_!!.WO'N&-RU!R1R*NX?%32$L3,MCHAVBN6(M=PFG"C!*CP;Z"E(?>\D6"A>
M"BFA<&+4ED YZMNE7=B"F)[MD9CV<MKK(H>(T7'F5='M8/:@)#-J5CGF59E>
MSOGG8% 2C"DQD!C9$92GB5>FF,*VD!;-""Z#%AB.06:?\T@BXJX"8BFQ\K@
M5B%^ +(_B  K_J3Z?JPE^  &*"!00'B7_FAU. WJTF/:6FU/L2D9/(FI"RVA
M+O2%J0L]8%KJO'TGH+2Y(F*1#PU.>PEX)Z\'<H @^0[^I>O*ZZT_%:L;7'O;
M>,6"H:NOU2S04V!X&LD;X_<>$P8M6(GF&W <\HX""Q SF<%1,[YQ" :SD&_*
M2V*+ !(MV8*M0[;H;0@*O*GH#*0_Z!\N(DAO$&#&N^7QY:6C>OF2@';#+NO
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M.3 U7VQA8BYX;6Q02P$"% ,4    "  'GR57:UA?@[X&  !#,0  %0
M        @ ','@  8W!I>"TR,#(S,#DP-5]P<F4N>&UL4$L! A0#%     @
M!Y\E5Y<';.97AP  =#H$ !X              ( !O24  &-U;6)E<FQA;F1P
I:&%R;2UA<FQO86YA9W)E+FAT;5!+!08     !0 % % !  !0K0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
